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Mycobacterial pathogens are responsible for an ongoing public health crisis. 
Mycobacterium abscessus is the causative agent of lung infections that disproportionately 
affect immunocompromised individuals and is the most intrinsically antibiotic-resistant 
bacterial species known. These characteristics make M. abscessus infections difficult to treat, 
with a success rate of only 45%. While some extensively resistant isolates are caused by 
mutations in drug targets, others appear to be a result of increased intrinsic drug resistance. 
Common among these strains is the presence of integrated viral genomes (prophage) that are 
known to contribute to fitness and antibiotic resistance in other pathogens but whose roles are 
largely unknown in mycobacteria.  
M. chelonae is an opprtunisitc pathogen that is closely related to M. abscessus. We have 
demonstrated that the presence of an M. abscessus cluster R prophage, McProf, in M. 
chelonae, increased resistance to antibiotics, such as amikacin, relative to strains lacking the 
 
  
prophage. The presence of McProf also enhances amikacin resistance in response to sub-lethal 
concentrations of antibiotics, or other cellular stresses such as infection by a second phage, 
BPs. Relative to strains carrying only one of the prophages or no prophage, the strain carrying 
two prophages, BPs and McProf, had the highest amikacin resistance. This strain also showed 
increased expression of the transcriptional activator, whiB7, which promotes expression of 
intrinsic antibiotic resistance genes. We investigated the role of BPs lysogenic gene products in 
the presence of McProf and showed that individual expression of these genes does not 
contribute to whiB7 upregulation, indicating that McProf likely plays a larger role in mediating 
this intrinsic resistance. We identified a McProf-encoded polymorphic toxin system and 
evaluated its effect on whiB7 expression in M. chelonae carrying the BPs prophage. The 
polymorphic toxin system elevates whiB7 expression but does not fully account for the 
dramatic increase in expression observed in the M. chelonae strain carrying both prophages.  
This work suggests that prophages play a role in increasing intrinsic antibiotic resistance 
and stress adaptation in pathogenic mycobacteria. Given that most pathogenic mycobacteria 
carry one or more prophages, characterizing how prophages regulate antibiotic resistance genes 






First, I would like to thank the late Dr. John Singer for listening to my interests during my 
orientation weekend and enrolling me in the MBMS Department when I had no idea where to 
begin to reach my goals. I would like to extend a very special thank you to Dr. Keith Hutchison, 
my first MBMS professor, for seeing my potential before I even believed in myself. It was 
because of your support and guidance that I pursued research experiences and ended up in the 
position to be writing a master’s thesis today. I will always cherish our conversations, scientific 
and otherwise. Of course, I’d like to thank Dr. Sally Molloy for taking me on as a research 
student at Keith’s request and keeping me around for the last 5 years. She has helped me 
develop as both a scientist and a role model, teaching me compassion along the way. Thank you 
to my thesis committee, Drs. Sally Molloy, Keith Hutchison, Josh Kelley, and Melody Neely for 
your guidance in my work. Thank you to all of the Molloy Lab members I have had the pleasure 
of working with over the years for providing assistance, laughs, and the occasional snacks. 
Thank you to everyone else in the MBMS Department for always ensuring a positive learning 
environment. Thank you to my mom and sister for never knowing how I spend my days but 
being proud of me just the same. And finally, a huge thank you to Dylan, my best friend, for 
your unwavering support through all of my endeavors. Thank you for doing everything you can 
to make my life easier even when I worked too much to make time for our family. Your actions 




TABLE OF CONTENTS 
ACKNOWLEDGEMENTS................................................................................................................. iv 
LIST OF TABLES............................................................................................................................... x 
LIST OF FIGURES............................................................................................................................ xi 
LIST OF ABBREVIATIONS ............................................................................................................. xiii 
CHAPTER  
1. REVIEW OF THE LITERATURE……………………………………………………………………………………………… 1  
1.1. Mycobacteria are a major public health threat………………………………………………… 1  
1.2. Emergence of multidrug resistance in pathogenic mycobacteria……………………… 3  
1.3. Transcriptional activator, whiB7, mediates antibiotic resistance……………………... 7 
1.4. Bacteriophage are the most abundant biological entity………………………………….. 11 
1.5. Prophage impact host fitness and virulence……………………………………………………. 13 
1.6. Mycobacterium chelonae as a model for studying pathogenic mycobacteria….. 16 
2. CHARACTERIZING THE ROLE OF PROPHAGE ON WHIB7 EXPRESSION AND ANTIBIOTIC 
RESISTANCE IN MYCOBACTERIUM CHELONAE………………………………………………………………..… 19 
2.1. Chapter Summary…………………………………………………………………………………………… 19  
2.2. Introduction……………………………………………………………………………………………………. 20 
2.3. Materials and Methods…………………………………………………………………………………… 23  
2.3.1. Bacterial and viral strains…………………………………………………………………….. 23 
2.3.2. Curing M. chelonae WT of its naturally occurring prophage………………… 25  




2.3.4. Isolation of lysogenic strains……………………………………………………………….. 28  
2.3.5. RNA isolations……………………………………………………………………………………… 29  
2.3.6. RNAseq and reap mapping………………………………………………………………….. 30  
2.3.7. cDNA synthesis and qRT-PCR………………………………………………………………. 31  
2.3.8. Minimum inhibitory concentration assays…………………………………………… 32  
2.4. Results…………………………………………………………………………………………………………..… 33  
2.4.1. Co-habitating prophage result in increased antibiotic resistance in M. 
chelonae……………………………………………………………………………………………… 33 
2.4.2. Isolations and characterization of BPs single lysogen and non-lysogen 
strains of M. chelonae…………………………………………………………………………. 36 
2.4.3. Strains of M. chelonae carrying McProf demonstrate increased resistance 
to aminoglycosides……………………………………………………………………….……… 38 
2.4.4. Prophage McProf enhances AMK resistance in response to sub-inhibitory 
concentrations of antibiotics……………………………………………………………….. 40 
2.4.5. Transcriptional activator, whiB7, is upregulated in double lysogens of M. 
chelonae……………………………………………………………………………………………… 42 
2.4.6. Upregulation of whiB7 only occurs in M. chelonae (BPs, McProf)………… 47 
2.4.7. Sub-inhibitory concentrations of ACI, but not AMK, increase whiB7 
expression in M. chelonae (BPs, McProf)……………………………………………… 49 
2.4.8. Characterization of the McProf prophage……………………………………………. 51 





2.5. Discussion……………………………………………………………………………………………………….. 56 
3. CHARACTERIZING THE ROLE OF PHAGE BPS ON WHIB7 EXPRESSION IN STRAINS OF 
MYCOBACTERIUM CHELONAE CARRYING MCPROF…………………………………………………………… 61 
3.1. Chapter Summary…………………………………………………………………………………………... 61  
3.2. Introduction………………………………………………………………………………………………….… 62  
3.3. Materials and Methods………………………………………………………………………………..…. 64  
3.3.1. Bacterial and viral strains…………………………………………………………………….. 64  
3.3.2. Isolation of lysogenic strains…………………………………………………………….…. 66  
3.3.3. Construction of recombinant strains……………………………………………………. 69  
3.3.4. RNA isolations……………………………………………………………………………………… 71  
3.3.5. cDNA synthesis and qRT-PCR………………………………………………………………. 72 
3.4. Results………………………………………………………………………………………………………..…… 73 
3.4.1. Organization of the BPs and CLED96 genomes and gene expression profile 
of BPs in the M. chelonae double lysogen (BPs, McProf)………………….….. 73 
3.4.2. BPs gp5 does not drive changes in whiB7 expression………………………..… 78 
3.4.3. BPs gp33 does not drive changes in whiB7 expression……………………..…. 80 
3.4.4. Co-expression of BPs gp5 and gp33 does not drive changes in whiB7 
expression…………………………………………………………………………………….…….. 82  
3.4.5. BPs gp58 does not drive changes in whiB7 expression………………………… 84 
3.5. Discussion……………………………………………………………………………………………………..… 85  
4. DETERMINING THE ROLE OF THE MCPROF POLYMORPHIC TOXIN CASSETTE ON WHIB7 




4.1. Chapter Summary………………………………………………………………………………………..…. 91  
4.2. Introduction………………………………………………………………………………………….………… 92  
4.3. Material and Methods…………………………………………………………………………………….. 97  
4.3.1. Bacterial and viral strains…………………………………………………………………….. 97  
4.3.2. RNA isolation…………………………………………………………………………………….… 98  
4.3.3. Construction of recombinant strains………………………………………………..…. 99  
4.3.4. Isolation of lysogenic strains……………………………………………………………… 101  
4.3.5. Phage particle release test…………………………………………………………………. 102 
4.3.6. cDNA synthesis and qRT-PCR………………………………………………………..…… 102 
4.3.7. Minimum inhibitory concentration assays…………………………………………. 103  
4.4. Results………………………………………………………………………………………………….………. 104  
4.4.1. Generation of recombinant M. chelonae strains………………………….……. 104 
4.4.2. Expression of the McProf polymorphic toxin cassette stabilizes BPs single 
lysogens of M. chelonae……………………………………………………….……………. 105 
4.4.3. The McProf polymorphic toxin cassette triggers upregulation of whiB7 in 
the presence of phage BPs…………………………………………………................. 106  
4.4.4. The McProf polymorphic toxin cassette is downregulated in M. chelonae 
(BPs, McProf)……………………………………………………………………………….……. 107  
4.4.5. Expression of the McProf polymorphic toxin cassette does not alter 
amikacin resistance………………………………………………………………………..…. 111  
4.5. Discussion……………………………………………………………………………………………….…….. 113 




LITERATURE CITED………………………………………………………………………………………………………….. 124  
























LIST OF TABLES 
Table 2.1 Bacterial and viral strains used in this study……………………………………………………….…… 24  
Table 2.2 Plasmids used in this study………………………………………………………………..……………………. 25  
Table 2.3 Standard PCR primers used in this study……………………………………………………….………… 27  
Table 2.4 qRT-PCR primers used in this study…………………………………………………………………………. 32  
Table 2.5 Minimum inhibitory concentrations of M. chelonae strains…………………………..……….. 34 
Table 2.6 Top 20 upregulated and downregulated genes in M. chelonae (BPs, McProf) relative 
to M. chelonae (McProf)…………………………………………………………………………………………….…………… 46 
Table 2.7 whiB7 regulon genes upregulated in M. chelonae (BPs, McProf) relative to M. 
chelonae (McProf)………………………………………………………………………………………………………..………… 47 
Table 3.1 Bacterial and viral strains used in this study…………………………………..……………………….. 65 
Table 3.2 Plasmids used in this study……………………………………………………………………..………………. 66 
Table 3.3 Standard PCR primers used in this study…………………………………………………………………. 68 
Table 3.4 qRT-PCR primers used in this study…………………………………………………………………………. 73 
Table 4.1 Bacterial and viral strains used in this study……………………………………………………….…… 98 
Table 4.2 Plasmids used in this study……………………………………………………………………………………… 98 
Table 4.3 Standard PCR primers used in this study……………………………………………………………….. 101 








LIST OF FIGURES 
Figure 1.1 Intrinsic mechanisms of antibiotic resistance in pathogenic mycobacteria………………. 5 
Figure 1.2 Phage replication cycles…………………………………………………………………………………………. 12 
Figure 2.1 Percent viability of M. chelonae (McProf) and M. chelonae (BPs, McProf) upon 
aminoglycoside treatment……………………………………………………………………………………………….…….. 36 
Figure 2.2 Percent viability of M. chelonae strains upon aminoglycoside treatment………..…….. 40 
Figure 2.3 Percent viability of M. chelonae strains upon AMK treatment in the presence and 
absence of ACI…………………………………………………………………………………………………………….…………. 41 
Figure 2.4 MA plot of M. chelonae (BPs, McProf) gene expression…………………………………………. 42 
Figure 2.5 WhiB7 protein alignment……………………………………………………………………………….……… 44 
Figure 2.6 qRT-PCR verification of RNAseq data……………………………………………………………….……. 45  
Figure 2.7 qRT-PCR analysis of whiB7 expression in M. chelonae strains………………………………… 48  
Figure 2.8 qRT-PCR analysis of whiB7 expression in M. chelonae strains in the presence and 
absence of ACI treatment………………………………………………………………………………………………………. 50 
Figure 2.9 qRT-PCR analysis of whiB7 expression in M. chelonae strains in the presence and 
absence of AMK treatment…………………………………………………………………………………………………….. 51  
Figure 2.10 Phamerator map of the McProf genome……………………………………………………….…….. 53 
Figure 2.11 McProf ESX-like polymorphic toxin cassette………………………………………………..………. 54 
Figure 2.12 Lysogenic gene expression profiles of BPs and McProf………………………………………… 56 
Figure 3.1 Phamerator map of the BPs integration cassette…………………………………………….…….. 75 




Figure 3.3 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs 
gp5…………………………………………………………………………………………………………………………………..…….. 80 
Figure 3.4 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs 
gp33……………………………………………………………………………………………………………………………….………. 82 
Figure 3.5 qRT-PCR analysis of recombinant M. chelonae (McProf) strains co-expressing BPs gp5 
and gp33………………………………………………………………………………………………………………………………… 83 
Figure 3.6 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs 
gp58…………………………………………………………………………………………………………………………..…………… 85 
Figure 4.1 Phage particle release in recombinant M. chelonae (BPs)……………………………..…….. 106 
Figure 4.2 qRT-PCR analysis of whiB7 in recombinant strains of M. chelonae expressing the 
McProf polymorphic toxin cassette………………………………………………………………………………………. 107  
Figure 4.3 2-∆∆Ct qRT-PCR analysis of polymorphic toxin cassette genes in recombinant M. 
chelonae strains……………………………………………………………………………………………………………..……. 109  
Figure 4.4 McProf polymorphic toxin cassette gene expression profile……………………….……….. 110  
Figure 4.5 ∆Ct qRT-PCR analysis of McProf polymorphic toxin cassette genes in recombinant M. 
chelonae strains ………………………………………………………………………………………………………….………. 111 
Figure 4.6 Percent viability of recombinant M. chelonae strains upon AMK treatment in the 













Basic Local Alignment Search Tool (BLAST) 
Bacteriophage Recombineering of Electroporated DNA (BRED) 
Clarithromycin (CLA)  
Clustered regularly interspaced short palindromic repeat interference (CRISPRi) 
Control of repressor’s operator gene (cro) 
Cystic fibrosis (CF) 
Deoxyribonucleic acid (DNA) 
Dimethyl sulfoxide (DMSO) 
Enterohemorrhagic E. coli (EHEC) 
Erythromycin ribosome methylase gene (erm) 
Excision gene (xis) 
Extensive drug resistance (XDR) 
False Discovery Rate (FDR) 
Glycerol kinase (glpK) 
Guide RNA (sgRNA) 






Latent tuberculosis infection (LTBI) 
Log2 fold change (Log2FC) 
Luria broth (LB)  
Messenger RNA (mRNA) 
Minimum inhibitory concentration (MIC) 
Multidrug resistance (MDR) 
Mycobacterium tuberculosis complex (MTBC) 
Non-tuberculous mycobacteria (NTM) 
Oleic acid, albumin, dextrose (OAD) 
Optical density at 600 nm wavelength (OD600) 
Phage Evidence Collection and Annotation Network (PECAAN) 
Plaque forming unit (PFU) 
Polymerase chain reaction (PCR) 
Polymorphic toxin (PT) 
Quantitative real-time polymerase chain reaction (qRT-PCR) 
Ribonucleic acid (RNA) 
Ribosomal RNA (rRNA) 
Shiga toxin gene (stx) 







Transfer RNA (tRNA) 
Tris-ethylenediaminetetraacetic acid (TE) 
Tuberculosis (TB) 
Type 6 secretion system (T6SS) 





REVIEW OF THE LITERATURE 
1.1 Mycobacteria are a major public health threat 
Mycobacteria are Gram-positive, non-motile, non-spore forming bacilli (Percival et al., 
2014). These species are characterized by their thick cell walls, including an outer layer studded 
with mycolic acid (Alderwick et al., 2015). Mycobacteria are ubiquitous in air, soil, and water 
(Percival et al., 2014). More than 170 species have been identified thus far, and can be 
characterized as obligate, opportunistic, or non-pathogens (Fedrizzi et al., 2017). Genetically, 
mycobacteria can be distinguished by 16S rRNA sequence homology and high GC content, as 
well as presence of mycolic acid biosynthesis markers (Fedrizzi et al., 2017). 
Mycobacteria are further grouped based on growth rate. The slow growth group requires 
more than 7 days to form colonies on solid media, while the rapid growth group forms colonies 
in 2 – 5 days (Bachmann et al, 2020). Slow-growing mycobacteria include obligate intracellular 
pathogens, such as M. tuberculosis, M. bovis, and M. leprae. Fast-growing species include both 
opportunistic pathogens and non-pathogens and are ubiquitous in the environment. Examples 
include pathogenic species, M. abscessus and M. chelonae, and non-pathogens, M. smegmatis 
and M. gilvum (Bachmann et al., 2020; Prasanna et al., 2013). Mycobacteria are also commonly 
characterized as belonging to the Mycobacterium tuberculosis complex (MTBC) or as non-
tuberculous mycobacteria (NTM). The MTBC consists of all strains capable of causing 
tuberculosis in humans (Fan et al. 2015). Tuberculosis continues to press a major economic and 




Prior to the COVID-19 pandemic, tuberculosis (TB), caused by Mycobacterium tuberculosis, 
was the leading cause of death by an infectious agent and still ranks in the top ten causes of 
death worldwide (WHO, 2020). Responsible for 2 billion current infections, 10 million new 
infections, and 1.4 million deaths in 2019, M. tuberculosis continues to thrive as a global health 
threat (WHO, 2020). Immunocompromised individuals, including those with human 
immunodeficiency virus (HIV), are especially susceptible to contracting TB, which is the leading 
cause of death among HIV-positive patients (WHO, 2020). TB is primarily a pulmonary disease, 
although disseminated infection is possible and is lethal in 50% of cases without 
chemotherapeutic intervention (Pai et al., 2016). M. tuberculosis is contracted through airborne 
transmission of respiratory droplets. Once inside the body, M. tuberculosis infects alveolar 
macrophage in the lungs. A collection of immune cells moves to encase the bacteria, resulting 
in granuloma formation. When bacterial cells are contained within granulomas, infection 
remains asymptomatic. However, the ability of M. tuberculosis to survive in macrophage leads 
to a persistent infection known as latent tuberculosis infection, or LTBI (Pai et al., 2016). If the 
bacterial load becomes too great for a granuloma to contain, cells will escape and can 
disseminate throughout the body and/or be expelled by the lungs. At this point, the patient has 
an active TB infection which is both symptomatic and contagious (Pai et al., 2016).  Symptoms 
of active infection include fever, fatigue, weight loss, cough, and in some cases, hemoptysis. 
These symptoms range in severity from mild to deadly (Pai, 2016). In addition to the health 
crisis caused by M. tuberculosis, incidence of disease caused by fast-growing opportunistic 
mycobacterial pathogens, especially M. abscessus, has been increasing (Bachmann et al., 2020; 




While not as prominent as M. tuberculosis, prevalence of NTM infections, especially M. 
abscessus infections, are on the rise, with a steep increase in the last decade (Johansen et al., 
2020). This increase can be attributed to environmental presence of NTM, as well as growing 
prevalence of risk factors, such as old age, immunosuppression, and chronic lung conditions, 
including cystic fibrosis. In fact, 10 – 20% of cystic fibrosis patients will develop M. abscessus 
infections (Johansen et al., 2020). While chance of infection is heightened in those with 
predispositions, NTM are capable of causing disease in otherwise healthy individuals as well 
(Johansen et al., 2020). Similar to TB, M. abscessus infection also results in granuloma 
formation, allowing the infection to persist for as long as several decades (Johansen et al., 
2020). In severe cases, M. abscessus may cross the blood-brain barrier and cause cerebral 
abscesses and meningitis (Hurst-Hess et al., 2017). Due to extensive antibiotic resistance, the 
incidence rate of M. abscessus infection is greater than that of M. tuberculosis in most 
developed countries, with a successful treatment rate of only 45% (Griffith, 2019; Johansen et 
al., 2020).  
1.2 Emergence of multidrug resistance in pathogenic mycobacteria 
Pathogenic mycobacteria are well known for intrinsic mechanisms of drug resistance that 
make effective treatment of infections difficult. In fact, M. abscessus is one of the most 
intrinsically resistant species known. While M. tuberculosis and M. abscessus share many 
features of intrinsic resistance, even frontline TB drugs are ineffective against this organism 
(Nessar et al., 2012). For this reason, the known mechanisms of drug resistance in M. abscessus 




Intrinsic resistance refers to naturally occurring characteristics that organisms possess to 
nullify the impact of antibiotics. The first line of defense in mycobacteria is the cell envelope. It 
is characterized as thick and waxy, with 60% lipid content. The structure of this envelope results 
in low permeability, making it difficult for antibiotics and other extracellular compounds to 
enter the cell (Nessar et al., 2012). Notably, mycobacteria have fewer porins spanning the cell 
envelope than observed in Gram-negative bacteria, further limiting antibiotic uptake (van Ingen 
et al., 2012). The membrane also works cooperatively with intracellular signals to shuttle 
unwanted compounds out of the cell (Nessar et al., 2012).  M. abscessus encodes numerous 
proteins that function to either modify antibiotics or alter the drug target itself to render the 
drugs inactive. Rifampicin resistance is conferred by an ADP-ribosyltransferase, arr, which 
modifies the drug by catalyzing the addition of an ADP-ribose group (Rominski et al., 2017). 
Acetylases and phosphotransferases, as well as the tap efflux pump are responsible for 
aminoglycoside resistance (Nessar et al., 2012; van Ingen et al., 2012). -lactamases degrade -
lactam antibiotics (Nessar et al. 2012). Several efflux pumps, including tap and tetV result in 
tetracycline resistance (van Ingen et al., 2012). Quinolone resistance is conferred through 
acetylases and efflux pumps, including lfrA (van Ingen et al., 2012). The erm methylase 
methylates 23S rRNA to prevent macrolide binding (Nash et al., 2009). The extent of intrinsic 





Standard treatment for active TB infection includes a four-drug regimen consisting of 
isoniazid, rifampicin, pyrazinamide, and ethambutol for a minimum of six months (Pai et al., 
2016; WHO, 2020). Treatment for M. abscessus infection involves a combination therapy of 
clarithromycin and amikacin, along with an injectable antimicrobial, such as cefoxitin. 
Treatment is long in duration, often 12 or more months, and can result in toxic side effects 
typical of amikacin treatment (Hurst-Hess et al., 2017). In severe cases, surgical intervention to 
remove infected tissue may be attempted (van Ingen et al., 2012). Treatment for both M. 
tuberculosis and M. abscessus infections has been further limited by emergence of multi-drug 
resistant (MDR) and extensively resistant (XDR) strains.  
 
Figure 1.1 Intrinsic mechanisms of antibiotic resistance in pathogenic mycobacteria. This 
schematic represents many mechanisms of intrinsic resistance displayed by M. abscessus, 
including drug efflux pumps and drug-modifying enzymes. Many of the genes responsible 





The definition and prevalence of MDR and XDR TB infections has been well characterized. 
MDR strains are resistant to both rifampicin and isoniazid. XDR strains are resistant to 
fluoroquinolones and at least one injectable aminoglycoside in addition to rifampicin and 
isoniazid (Pai et al., 2016). The WHO estimates that 3.3% of new cases and 18% of existing cases 
are MDR, with a 10% increase in treatment of MDR strains since 2017 (WHO, 2020). 
Additionally, 12,350 people developed XDR infections in 2019 (WHO, 2020). All acquired 
antibiotic resistance observed in M. tuberculosis thus far are a result of spontaneous point 
mutations within drug targets (Nasiri et al., 2017). Resistance to isoniazid, rifampicin, 
pyrazinamide, and ethambutol are caused by mutations in katG, rpoB, pncA, and embCAB 
respectively (Nasiri et al., 2017).   
The prevalence of M. abscessus infections is not as well quantified and are often 
misidentified. However, the incidence of new M. abscessus infections has been on the rise over 
the last decade (Johansen et al., 2020). While M. abscessus is already intrinsically resistant to 
most drug groups, strains have also acquired additional resistance to aminoglycosides, 
macrolides, or both. In fact, some strains have developed resistance to all known antibiotics 
(Johansen et al., 2020). Spontaneous point mutations in rrs, which encodes 16S rRNA, are 
associated with aminoglycoside resistance (Nessar et al., 2012; Guo et al., 2020; Johansen et al., 
2020). To date, four possible point mutations have been identified that confer this resistance 
(Nessar et al., 2012). Point mutations within the 23S rRNA encoding-gene, rrl, leads to 
macrolide resistance (Guo et al., 2020; Johansen et al., 2020). However, not all extensively 
resistant phenotypes can be attributed to genetic mutations, suggesting that other unidentified 




MDR strains is the upregulation of transcriptional activator, whiB7, which regulates genes that 
confer intrinsic antibiotic resistance (Guo et al., 2020). 
1.3 Transcriptional activator, whiB7, mediates antibiotic resistance  
The whiB family (whiB1 – 7) of genes are a group of transcriptional regulators found in the 
Actinomyces genus, which includes significant pathogenic species such as mycobacteria, 
streptomyces, and nocardia (Burian et al., 2015; Barka et al., 2016). These transcription factors 
are characterized by four conserved cysteine residues and a helix-turn-helix DNA binding motif 
(Larsson et al., 2012). Each of the seven genes of the whiB family contributes to virulence, and 
the majority have been assigned additional functions (Bush, 2018). whiB1, whiB3, whiB4, and 
whiB7 assist in maintaining redox balance. whiB2 plays a role in cell growth and septation. 
whiB7 plays an especially pivotal role in virulence by regulating genes involved in antibiotic 
resistance and survival in macrophage (Morris et al., 2005; Burian et al., 2015; Bush, 2018). 
  whiB7 is a transcriptional activator that mediates genes directly involved in antibiotic 
resistance, as well as antibiotic-induced stress response genes, including those involved in 
redox and metabolism (Morris et al., 2015; Burian et al., 2012). It has a signature structure that 
includes four conserved cysteine residues, a G(V/I)WGG turn, and a C-terminal AT-hook 
necessary for DNA binding (Burian et al., 2013). Expression of whiB7 occurs from an antibiotic-
inducible promoter and is transcribed by a SigA-containing RNA polymerase (Burian et al., 
2018). In addition, the whiB7 promoter contains an AT-rich motif that allows WhiB7 to bind and 
amplify its own expression, making it autoregulatory (Burian et al., 2013). Burian et al. (2015) 
identified 86 drugs capable of inducing the whiB7 promoter after screening 600 compounds, 




belong to a variety of structural and drug target groups. whiB7 is also upregulated 14-fold in M. 
tuberculosis when cells are introduced into murine macrophage (Larsson et al., 2012). It is 
predicted that this induction is caused by the reducing agent, glutathione, encountered in 
macrophage (Burian et al., 2015).  
 Interestingly, the whiB7 promoter is constitutively active at a low level in the absence of 
antibiotics, however the whiB7 open reading frame (ORF) itself is not transcribed due to the 
presence of a Rho-independent terminator upstream of the whiB7 ORF. An upstream ORF 
(uORF) located between the whiB7 promoter and terminator is predicted to act, in conjunction 
with the terminator, as a riboregulatory attenuation system (Burian et al., 2018). In these 
systems, the presence of a regulatory metabolite can affect translation of the uORF, which in 
turn alters the secondary structure of the terminator sequence. This results in anti-termination 
and subsequent transcription of the downstream gene (Dar et al., 2016). In the case of whiB7, 
anti-termination is achieved through exposure to sub-lethal concentrations of antibiotics and 
other biologically active compounds (Burian et al., 2018). Once translated, WhiB7 stimulates 
expression of other genes within its regulon, including tap, tetV, and eis, by binding to the SigA 
subunit of RNA polymerase and directing it to target genes (Burian et al., 2018).  
While whiB7 homologs are conserved in mycobacteria, the number and function of genes 
within the regulon differs between species. M. tuberculosis encodes 12 genes belonging to the 
WhiB7 regulon, only four of which contribute to antibiotic resistance (tap, eis, erm, and tetV) 
(Morris et al., 2005; Shur et al., 2017). In contrast, M. abscessus encodes 128 genes belonging 




with direct roles in intrinsic antibiotic resistance that are upregulated upon whiB7 induction via 
drug exposure (Hurst-Hess et al., 2017).  
WhiB7 regulates an erythromycin ribosome methylase (erm) that contributes to resistance 
to macrolides, a frontline ribosome-targeting drug family used to treat M. abscessus infections 
(Luthra et al., 2018). They cease protein synthesis by targeting the polypeptide exit tunnel and 
causing tRNA dissociation (Luthra et al., 2018). The erythromycin ribosome methylase, or erm, 
methylates 23S rRNA at the A2058 position to lower macrolide binding affinity (Luthra et al., 
2018). An erm homolog, erm(41), is regulated by whiB7 and confers macrolide resistance in two 
of three M. abscessus subspecies (M. massiliense lacks this gene) (Nash et al., 2009).  
Efflux pumps are energy-dependent membrane proteins that export compounds out of cells 
(Ramon-Garcia et al., 2012). A tetracycline/aminoglycoside efflux pump (tap) is regulated by 
whiB7 and, as the name suggests, confers resistance to tetracyclines and aminoglycosides by 
shuttling them out of the cell (Ramon-Garcia et al., 2012). Shur et al. (2017) have also provided 
evidence that Tap is capable of exporting macrolides and fluoroquinolones. In addition, Tap 
plays a role in stationary phase survival, and therefore latency, by shuttling toxic waste 
products out of the cell (Ramon-Garcia et al., 2012). 
 whiB7 controls the expression of several GCNS-related N-acetyltransferase (GNAT) family 
genes in M. abscessus (Luthra et al., 2018). This family includes the enhanced intracellular 
survival, or eis, gene known for its role in macrophage intracellular survival and kanamycin 
resistance in M. tuberculosis (Chen et al., 2012). N-acetyltransferases target aminoglycosides. 
Aminoglycosides, like macrolides, inhibit protein synthesis. However, they do so by binding 16S 




acetyltransferases are conserved in mycobacteria and acetylate aminoglycosides with a 2’ 
amino group, including gentamycin, tobramycin, and kanamycin (Luthra et al., 2018). The whiB7 
regulon of M. abscessus encodes two eis genes. eis1 is a homolog of the eis gene in M. 
tuberculosis. eis2 is a homolog of the eis gene in Anabaena variabilis and is significant in that it 
confers resistance to amikacin, a frontline drug used to treat M. abscessus infection (Luthra et 
al., 2018). In terms of intracellular survival, eis acetylates, and therefore activates, phosphatase 
16/mitogen-activated protein kinase phosphatase-7 (DUSP16/MPK-7). DUSP16/MPK-7 inhibits 
death of infected macrophage (Luthra et al., 2018).  
Many MDR and XDR isolates of M. abscessus demonstrate a >10-fold increase in whiB7 
expression, along with an increase in expression of associated antibiotic resistance genes, 
relative to drug-susceptible strains (Wu et al., 2019). The cause of this upregulation is not 
known; however, it is hypothesized that exposure to sub-inhibitory clarithromycin as a result of 
drug concentration gradients encountered in tissues during treatment of M. abscessus infection 
results in upregulation of whiB7 (Pryjma et al., 2017). Similarly, reduced drug penetration 
observed during treatment of M. tuberculosis infection is associated with acquired drug 
resistance, although whether whiB7 expression is impacted has not been measured (Dheda et 
al., 2018). There is also evidence that prophage can alter bacterial antibiotic resistance (Wang 
et al., 2010). While prophage-encoded virulence genes appear to be more abundant in 
mycobacteriophage identified in clinical isolates of pathogenic NTM compared to 
environmental mycobacteriophage, their impact on increased antibiotic resistance has not 





1.4 Bacteriophage are the most abundant biological entity 
Bacteriophage (phage) are viruses that infect bacteria (Haq et al., 2011). They are the 
most abundant biological entity on Earth, quantified at approximately 1031 particles (Suttle, 
2016). The majority of phage belong to the order Caudovirales, or tailed, double-stranded DNA 
phage, rather than the Inoviridae, or filamentous phage group (Hatfull and Hendrix 2011; 
Knezevic et al., 2021). The structure of these phage particles consists of an icosahedral head 
that encapsulates genetic material, as well as a fibrous tail. Tailed phage are categorized into 
three different families based on tail structure: myoviridae (contractile tails), siphoviridae (long, 
non-contractile tails), and podoviridae (short non-contractile tails), and possess incredibly 
diverse genomes (Hatfull and Hendrix 2011). As of January 2021, 18,679 Actinobacteria phages 
have been isolated, and 3,698 of these have been fully sequenced and characterized (Russell 
and Hatfull, 2017). Of these phages, 11,468 are able to infect mycobacteria. Phage are 
categorized by cluster. Phage within the same cluster share at least 35% shared gene content 
(Pope et al., 2017; Dedrick et al., 2021). To date, there are 140 clusters and 157 subclusters. 
There are 63 phages with no known relatives which belong to the singleton cluster (Russell and 
Hatfull, 2017).  
Phage replicate by two distinct pathways: the lytic and lysogenic cycle. Phage infection 
begins with attachment to the host cell via interactions with a specific host cell receptor, 
followed by transfer of genetic material into the bacterial host (Stone et al., 2019). Lytic phage 
strictly replicate through the lytic cycle and use host machinery to propagate within the cell, 
beginning with replication of genetic material, then expression of particle structural proteins. 




with viral particles, phage-encoded proteins (holins and lysins) facilitate cell lysis, releasing 
progeny into the extracellular environment (Haq et al., 2011). The progeny then moves on to 
infect other cells and repeat the process. Temperate phages are capable of carrying out both 
the lytic and lysogenic cycle. During lysogeny, the phage genome is inserted into the genome of 
the bacterial host via phage- and host-encoded proteins. The bacterium carrying the integrated 
phage genome is called a lysogen. Once a phage is integrated into its host, it is termed a 
prophage. The prophage genome remains latent, replicating along with the bacteria (Haq et al., 
2011). 
 
Temperate phage, those able to form lysogens, typically maintain lysogeny through 
expression of an immunity repressor gene which serves as a transcriptional regulator to inhibit 
expression of phage replication and structural elements typical of lytic growth. Repressors also 
confer immunity to infection by related phage. (Petrova et al., 2015). However, a process 
 
Figure 1.2 Phage 
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known as induction may occur randomly in a small fraction of cells, or in response to stress in a 
large fraction of cells. During this process, concentrations of the immunity repressor decrease 
in the cell, allowing expression of lytic genes and the production of virions (Casjens, 2003). 
Some temperate phages additionally encode a repressor gene, control of repressor’s operator 
(cro), which promotes lytic gene expression and replication by inhibiting expression of the 
immunity repressor (Gao et al., 2013). Lytic phages are now being harnessed for their ability to 
kill bacterial cells (Dedrick et al., 2019).  
Lytic phages, and phages engineered to be lytic, have the potential to revolutionize 
medicine by providing an alternative to antibiotic treatment, specifically in regard to bacteria 
that have developed multi-drug resistance (Dedrick et al., 2019; Jault et al., 2018; Altamirano et 
al., 2019). Phage therapy utilizes the lytic aspect of viruses as means to target and destroy 
pathogenic bacteria (Hatfull, 2014). In fact, phage therapy was successfully employed recently 
to treat a CF patient with a lethal MDR M. abscessus infection following lung transplantation 
(Dedrick et al., 2019). A cocktail of three phages (Muddy, ZoeJ, and BPs) were given both 
intravenously and topically twice daily for 32 weeks to treat disseminated and wound 
infections. Two of the phages, ZoeJ and BPs, lytically infected M. abscessus at a poor efficiency. 
To remediate this, the phages were genetically engineered to remove their respective immunity 
repressor genes to force strictly lytic infections (Dedrick et al., 2019). Prior to this treatment 
regimen, the patient, only 15 years old, had been placed on palliative care as a result of the 
infection. Throughout treatment, the patient improved clinically, skin nodules resolved, and M. 
abscessus was no longer detectable in sputum. This is the first example where phage therapy 




The results of this study are promising for future treatment of XDR M. abscessus 
infections and has paved the way for development of phage therapies aiming to prevent and 
treat other mycobacterial infections, especially M. tuberculosis. Carrigy et al. (2019) has 
demonstrated that inhalation of nebulized mycobacteriophage, D29, is an effective prophylactic 
measure for M. tuberculosis infection in mice, modeling a potential preventative treatment 
option for high-risk individuals. Additionally, a five-phage cocktail has been developed to target 
the MTBC and was successful in killing M. tuberculosis strains in vitro (Guerro-Bustamante et 
al., 2021).  While lytic phages may be harnessed to treat bacterial infections, prophage may 
enhance infections by increasing fitness and virulence of its host.  
1.5 Prophage impact host fitness and virulence 
 The presence of prophage is extensive in bacterial pathogens and likely play a significant 
role in bacterial evolution (Brussow et al., 2004). Up to 20% of bacterial chromosomes consist 
of prophage or prophage-like elements (Fan et al., 2014). Interestingly, genes expressed from 
prophage may alter the host in a beneficial manner and phage-encoded genes have been 
shown to increase virulence, antibiotic resistance, and antibiotic tolerance in lysogen 
populations (Casjens, 2003; Kaper et al., 2004; Hyder and Streitfeld, 1978; Muniesa et al., 2013; 
Wang et al., 2016).  
 Prophage-encoded toxins are the most obvious mechanism of increasing pathogenesis 
(Wang et al., 2016). For example, Shiga toxin (stx)-encoding prophage are present in bacterial 
strains responsible for enterohemorrhagic Escherichia coli (EHEC) infections that result in 
bloody diarrhea and other complications (Kaper et al., 2004). The toxin is only expressed during 




encoding prophage into lytic replication, therefore resulting in toxin production (Kaper et al, 
2004). Similarly, the filamentous phage, Pf4, that resides in Pseudomonas aeruginosa influences 
biofilm formation (Webb et al., 2004; Rice et al., 2009). This is not a result of a phage-encoded 
toxin but demonstrates a direct role in increasing virulence. The presence of Pf4 makes 
treatment of P. aeruginosa infection difficult and is especially detrimental to CF patients who 
often harbor persistent infections (Webb et al., 2004; Wang et al., 2016). 
 Prophages may serve as genetic switches to regulate bacterial gene expression under 
different conditions if integration disrupts gene function (Rabinovich et al., 2012). For example, 
Listeria monocytogenes, a human pathogen, encodes a competence system necessary for 
phagosomal escape and intracellular growth. This system is rendered nonfunctional due to the 
presence of prophage, A118, that integrates into the competence system activator, comK 
(Rabinovich et al., 2012). A118 serves as a genetic switch by excising from the host genome, but 
not entering lytic growth, upon encountering the intracellular environment of macrophage. 
Excision results in an intact comK, leading to activation of the competence system and 
establishment of intracellular infection (Rabinovich et al., 2012). 
 Prophage can also contribute to increased antibiotic resistance. Some cases are a result 
of direct introduction of a resistance gene. An example of this is found in Streptococcus 
pyogenes. MDR variants of S. pyogenes are predicted to be a result of acquired macrolide 
resistance through introduction of a prophage-encoded erm (Hyder and Streitfeld, 1978). 
Prophages influence antibiotic resistance in other models where the mechanisms of how they 
do so remain unknown. For example, a study done by Wang et al. (2010) on E. coli K12 carrying 




prophage contribute to antibiotic resistance. They conducted a curing experiment and found 
that antibiotic sensitivity increased as the number of prophages decreased, with the strain 
lacking all prophages being the most sensitive (Wang et al., 2010).  
 Toxin-antitoxin (TA) systems are abundant in bacteria and are associated with increased 
virulence (Slayden et al., 2018; Harms et al., 2018). These genes may be encoded by the 
bacterial genome but are also frequently encoded on mobile elements, including prophages 
(Corray et al., 2017; Harms et al., 2018; Leplae et al., 2011; Dedrick et al., 2017; Harms et al., 
2017). However, the mechanisms by which they may increase bacterial virulence is largely 
unexplored (Yao et al., 2018). TA systems consist of two genes that are typically adjacent and 
transcribed together. The toxin interrupts cellular processes, often by interfering with or 
degrading genetic material. The antitoxin binds and neutralizes the toxin (Wang et al., 2011). 
Several functions of prophage-encoded TA systems have been identified. First, TA systems can 
aid in bacterial persistence by altering the metabolic rate of the cell, allowing it to withstand 
antibiotic exposure and other stressors (Wood, 2016). Additionally, prophage-encoded TA 
systems have been shown to mediate biofilm formation in E. coli (Wang et al., 2011).  TA 
systems are also known to stabilize mobile elements such as plasmids and prophages. This is 
the case with the ParE/CopA TA system encoded by the CP4So prophage found in Shewanella 
oneidensis (Yao et al., 2018). It has also been demonstrated that prophage encoded TA systems 
can confer abortive infection (Dedrick et al., 2017). Prophage-encoded TA systems are triggered 
upon infection by another phage. The antitoxin is degraded, and the toxin induces altruistic 
suicide of the cell. Sacrificing the cell prevents lytic phage proliferation, thereby protecting the 




 One or more prophage/prophage-like elements have been identified in sequenced 
pathogenic mycobacterial strains; however, their roles remain to be fully characterized (Fan et 
al., 2014). All strains of M. tuberculosis carry prophage Rv1,  Rv2, or both (Fan et al., 2015). 
M. bovis BCG, the vaccination strain, lacks these prophages due to deletions, and interestingly, 
are unable to cause infections in humans. Work done by Fan et al. (2015) demonstrated that 
several prophage genes are upregulated in M. tuberculosis during both nutrient starvation and 
oxygen depletion. The mechanism of how these genes contribute to fitness has yet to be 
identified but it makes sense that they play a role in stress adaptation of mycobacterial 
intracellular pathogens (Fan et al., 2015).  
1.6 Mycobacterium chelonae as a model for studying the role of prophage in pathogenic 
mycobacteria  
 M. chelonae, a member of the M. abscessus/M. chelonae complex, is a rapidly growing 
opportunistic human pathogen (Jaen-Luchoro et al., 2016). While it is primarily known as a 
cause of mycobacteriosis in marine organisms due to its high abundance in water systems, it is 
also a common cause of skin and soft tissue infections in humans (Jacobs et al., 2009). This is 
especially prevalent in healthcare settings, where M. chelonae is isolated from post-surgical 
wounds, implants, catheters, and dialysis ports (Jaen-Luchoro et al., 2016). It is also responsible 
for corneal infection (de Moura et al., 2014). M. chelonae rarely causes lung or disseminated 
disease, but it is possible in high-risk groups, including CF patients (Jaen-Luchoro et al., 2016).  
 The wild-type M. chelonae genome (CCUG 47445) spans 5,029,817 bp, contains 4,726 
predicted coding sequences, and has a GC content of 64% (Jaen-Luchoro et al., 2016). It is a 




sequence identity at the protein-coding level. In fact, M. abscessus was previously misidentified 
as M. chelonae due to nearly identical biochemical and morphological features. M. abscessus 
was not recognized as a separate species until 1992 (de Moura et al., 2014).  
Despite the homology and identical biosafety level (BSL-2) between the two species, M. 
chelonae is safer to work with, making it an ideal pathogenic mycobacterial model in a 
laboratory setting. The optimal growth temperature of M. chelonae is 30˚C, and it cannot grow 
at 37˚C (the internal temperature of the human body), providing an explanation as to why it is 
the causative agent of primarily superficial infections (Johansen et al., 2020). M. chelonae is a 
fast-growing model organism relative to other mycobacteria, with a generation time of 
approximately 5 hours. While it has a similar antibiotic resistance profile to M. abscessus, M. 
chelonae lacks erm, making it susceptible to macrolides and therefore providing an effective 
treatment option (Nash et al., 2009). In addition, M. chelonae is able to infect both murine and 
human macrophage cell lines, as well as zebrafish, making both in vitro and in vivo studies 
possible (Whipps et al., 2008).  
M. chelonae is also an ideal model for studying the role of prophage in pathogenic 
mycobacteria. It carries a naturally occurring cluster MabR prophage named McProf that has 
been identified in clinical isolates of M. abscessus and is also susceptible to infection by 
mycobacteriophage that include both M. abscessus and M. tuberculosis in their host ranges 







CHAPTER 2  
CHARACTERIZING THE ROLE OF PROPHAGE ON WHIB7 EXPRESSION AND ANTIBIOTIC 
RESISTANCE IN MYCOBACTERIUM CHELONAE 
This chapter is a modified version of the following manuscript: Cushman J, Freeman E, 
McCallister S, Schumann A, Hutchison KW, Molloy SD. (2021) Increased whiB7 expression and 
antibiotic resistance in Mycobacterium chelonae carrying two prophages. BMC Microbiology, 
21(176) doi: 10.1186/s12866-021-02224-z  
2.1 Chapter Summary 
Mycobacterium abscessus is the most intrinsically antibiotic-resistant species known. It is 
the causative agent of lung infections that disproportionately affect immunocompromised 
individuals. These characteristics make M. abscessus infections difficult to treat, with a success 
rate of only 45% (Griffith, 2019; Johansen et al., 2020). While some extensively resistant 
isolates are caused by mutations in drug targets, others appear to be a result of increased 
intrinsic drug resistance (Guo et al., 2020). Common among pathogenic mycobacteria is the 
presence of integrated viral genomes (prophage) that are known to contribute to fitness and 
antibiotic resistance in other pathogens but whose roles are largely unknown in mycobacteria 
(Fan et al., 2014; Fan et al., 2015; Bibb and Hatfull, 2002).  
We have demonstrated that the presence of an M. abscessus cluster R prophage, McProf, in 
M. chelonae ATCC®35752 increased resistance to antibiotics such as amikacin, relative to 
strains lacking the prophage. The presence of McProf also enhances amikacin resistance in 
response to sub-lethal concentrations of antibiotics, or other cellular stresses such as infection 




the strain carrying two prophages, BPs and McProf, had the highest amikacin resistance. This 
strain also showed increased expression of the transcriptional activator, whiB7, which promotes 
expression of intrinsic antibiotic resistance genes (Morris et al., 2005; Burian et al., 2012). This 
work suggests that prophages play a role in increasing intrinsic antibiotic resistance and stress 
adaptation in pathogenic mycobacteria. Given that most pathogenic mycobacteria carry one or 
more prophages and encounter drug gradients in tissues during infection, characterizing how 
prophages regulate antibiotic resistance genes and adaptation to stresses will provide insight 
for developing more effective therapies for mycobacterial diseases.  
2.2 Introduction 
Prophage (integrated viral genomes) are major drivers of bacterial virulence and 
antibiotic resistance in bacteria, yet the mechanisms of prophage-mediated antibiotic 
resistance are unknown (Wang et al, 2010; Wang et al., 2016). Prophages are common in 
mycobacteria, including clinical isolates of emerging non-tuberculosis pathogenic mycobacteria, 
Mycobacterium avium and M. abscessus (Fan et al., 2014; Glickman et al., 2020). M. abscessus 
is the causative agent of lung infections that disproportionately affects immunocompromised 
individuals and is one of the most intrinsically antibiotic-resistant species known (Griffith, 2019; 
Johansen et al., 2020).  Extensively resistant isolates share increased expression of conserved 
mycobacterial intrinsic antibiotic resistance genes such as whiB7, making drug treatment 
challenging (Griffith, 2019; Guo et al., 2020). Understanding how intrinsic antibiotic resistance 
genes are regulated in pathogenic mycobacteria would provide opportunities to develop novel 




Currently, the only effective treatment option is combination therapy of amikacin (AMK) 
and clarithromycin (CLA), along with an injectable antimicrobial such as cefoxitin, for as long as 
2 years with harsh side effects (Hurst-Hess et al., 2017). Recent efforts in sequencing of clinical 
M. abscessus isolates determined that mutations in the 23S rRNA gene, rrl, and in the erm 
gene, which confers macrolide (e.g. clarithromycin) resistance, are typically associated with 
elevated CLA resistant phenotypes but did not account for all the clarithromycin resistant 
phenotypes (Guo et al., 2020). Consistent among all clarithromycin-resistant isolates was 
elevated expression of genes in the whiB7 regulon, including the transcription factor whiB7 and 
its target genes such as drug efflux pumps and antibiotic resistance genes, erm and eis (Burian 
et al., 2013; Hurst-Hess et al., 2017; Guo et al., 2020). These latter genes confer macrolide and 
aminoglycoside resistance, respectively. Likewise, in AMK-resistant isolates of M. abscessus 
there is typically a 10-fold increase in whiB7 expression relative to AMK susceptible strains (Wu 
et al., 2019).  
whiB7 is conserved across all mycobacteria, including pathogenic and non-pathogenic 
species such as M. tuberculosis, M. abscessus, M. chelonae and M. smegmatis (Morris et al., 
2005; Burian et al., 2012). whiB7 is upregulated in the presence of environmental stressors, 
including the intracellular environment of a macrophage and exposure to subinhibitory drug 
concentrations, but the cause of upregulation in extensively resistant M. abscessus is not well 
understood (Morris et al., 2005; Burian et al., 2012).  Characterizing the pathways that lead to 
increased whiB7 expression and intrinsic drug resistance in pathogenic mycobacteria will be 
important for identifying new targets for novel drug development (Nessar et al., 2012; Dheda et 




Prophages are present in most bacterial pathogens and contribute to virulence and 
antibiotic resistance (Brussow et al., 2004; Wang et al., 2016). In some models, the role and 
mechanism of prophage impact is clear. E. coli 0157:H7 causes enterohemorrhagic disease and 
is pathogenic due to a toxin encoded by the Stx prophage (Kaper et al., 2004). In other models, 
the role is of prophage clear, but the mechanism is not understood. E. coli K12 carries 9 cryptic 
prophages (transcriptionally active prophage that cannot carry out lytic infections) (Wang et al., 
2010). Wang et al. (2010) showed that as the number of prophages decreased through a series 
of curing experiments, so did resistance to antibiotics. The strain lacking all prophages was 
most susceptible to drugs. Toxin/antitoxin (TA) systems encoded by prophage are also known 
to increase resistance and persistence in the presence of antibiotics. In E. coli, prophage-
encoded TA pair RalR/RalA increases resistance to broad-spectrum fosfomycin and the RelE 
toxin of prophage Qin leads to persistence in the presence of ciprofloxacin, ampicillin and 
tobramycin (Christensen et al., 2001; Guo et al., 2014; Neubauer et al., 2009). The majority of 
mycobacterial pathogens also carry prophage, and they are hypothesized to play a role in 
virulence yet remain largely uninvestigated (Fan et al., 2014; Fan et al., 2015; Bibb and Hatfull, 
2002). However, it has been shown that removal of prophage from M. tuberculosis renders it 
nonpathogenic (Fan et al., 2015). This suggests that mycobacterial prophages are necessary for 
the success of their pathogenic hosts.  
In this study we examine the impact of two mycobacteriophages on intrinsic antibiotic 
resistance and whiB7 expression in the non-tuberculous mycobacterial pathogen, M. chelonae, 
a member of the M. abscessus/chelonae complex. The disease caused by M. chelonae, mainly 




dependent mechanisms of intrinsic resistance are conserved across all mycobacteria, including 
M. chelonae (Morris et al., 2005; van Ingen et al., 2009). Additionally, M. chelonae shares 103 of 
the 128 genes belonging to the whiB7 regulon in M. abscessus (Hurst-Hess et al., 2017). We 
identified a naturally occurring prophage in M. chelonae that also occurs in the sequenced 
genomes of at least 25 clinical isolates of M. abscessus (Molloy, Unpublished). We characterized 
the genome of the M. chelonae prophage, McProf, and created a cured strain that lacks 
prophage. Antibiotic resistance and gene expression of this strain was compared to that of M. 
chelonae carrying a single or multiple prophages.  
2.3 Materials and Methods 
2.3.1. Bacterial and viral strains 
 Mycobacterium chelonae (ATCC®35752, American Type Culture Collection, Manassas, 
VA) was grown in liquid Middlebrook 7H9 broth (BD, Sparks, MD) supplemented with 10% oleic 
acid, albumin, dextrose (OAD) and 0.05% Tween 80 at 30˚C with shaking at 230 RPM. Tween 80 
was excluded from bacterial cultures used in minimum inhibitory concentration and phage 
infection assays. The wildtype strain of M. chelonae carries a naturally occurring prophage, 
McProf, and will be referred to as M. chelonae (McProf). Kanamycin was used as a selective 
measure for recombinant strains at a concentration of 250 μg mL-1 in liquid and solid media. 
Competent E. coli DH5  cells were prepared by New England Biolabs, (Ipswich, MA) and grown 
in Luria broth base, Miller (BD) supplemented with 50 μg mL-1 of kanamycin at 37˚C with 
shaking at 230 RPM for propagation of plasmids. Bacterial strains used in this study are listed in 




Mycobacteriophage BPs was obtained from the Hatfull Laboratory and cultivated by plaque 
assay using M. chelonae (McProf) or M. smegmatis MC2155 (Sampson et al., 2009). Serially 
diluted phage samples were incubated for 15 min at room temperature in 0.5-mL aliquots of 
late log phase bacteria. Aliquots were plated in 4.5 mL of 0.45% 7H9 top agar onto 7H10 agar 
plates. High titer phage lysate stocks were generated by flooding bacterial lawns with nearly 
confluent lysis with phage buffer (10 mM Tris/HCl pH 7.5, 10 mM MgSO4, 1 mM CaCl2, 68.5 mM 



























2.3.2 Curing M. chelonae WT of its naturally occurring prophage  
Mycobacterial expression vector, pST-KT (Parikh et al., 2013) carries a tetracycline-
inducible promoter and kanamycin resistance gene. Curing M. chelonae (McProf) of its naturally 
occurring prophage was achieved by overexpression of the McProf excision (xis) gene (McProf 
gp5). pST-KT was digested with BamHI and HindII to linearize the vector, removing a 67-bp 
fragment according to the manufacturer’s recommendations (New England Biolabs, Ipswich, 
MA). Linearized vector was purified on a DNA clean-up column (NEB). An overexpression vector 
was constructed by cloning a 292-bp G-block (Integrated DNA Technologies, Coralville, IA) that 
included 27 bp and 24 bp of plasmid sequences that flank the 5’ and 3’ ends of digested vector 
respectively, and an internal sequence that corresponds to the McProf gp5 ORF (3,169 – 3,405 
bp) into M. chelonae (McProf) via Gibson Assembly (NEB). Resulting plasmid was transformed 
into competent E. coli DH5  according to the manufacturer’s recommendations and plated on 
selective L agar supplemented with 50 µg mL-1 of kanamycin (KAN). Recombinant plasmid, 
referred to as pST-KT_xis was propagated in E. coli DH5 and sequenced to ensure presence of 
xis.  
pST-KT_xis was electroporated into competent M. chelonae (McProf) according to de 
Moura et al. (2014) and PCR screened for presence of the plasmid (Table 2.3).  Briefly, 








times. Plasmid DNA in 500 ng quantities were electroporated with 100 µL of electrocompetent 
M. chelonae in 0.2-cm gap cuvettes. A sample of electrocompetent cells lacking plasmid DNA 
served as a negative control. Electroporation was carried out in a single pulse at 2.5 kV, 25 mF, 
1,000 Ω. Cells were suspended in 900 µL of room-temperature 7H9-OAD and incubated at 30˚C 
with shaking for 4 h prior to plating on 7H10-OAD agar plates supplemented with 250 µg mL-1 of 
KAN. Transformant colonies were PCR screened for presence of the plasmid (Table 2.3).   
The recombinant strain was grown for 48 h at 30˚C with shaking and sub-cultured to an 
optical density of 0.05 measured at a wavelength of 600 nm (OD600). Cultures were then grown 
to an optical density of 0.6 and treated with 500 g mL-1 of anhydrotetracycline (ATc) prepared 
in dimethyl sulfoxide (DMSO) or an equal volume of DMSO before incubating for an additional 
72 h at 30˚C with shaking. A 0.5-mL sample from treated and mock-treated cultures was 
harvested, serially diluted, and plated in 100-L volumes onto 7H10-OAD supplemented with 
250 g mL-1 of KAN. Plates were then incubated for 5 d at 30˚C. Bacterial colonies were lysed 
and PCR screened for loss of McProf using a set of four primers that amplify either attL and attR 
sites (indicating integrated prophage) or attB and attP sites (indicating excised prophage) 
(Table 2.3). PCR products showing intact an intact attB site were sequenced to confirm 
complete loss of prophage sequence. The resulting cured strain is referred to as M. chelonae 





2.3.3 McProf genome annotation  
 Phaster (Arndt et al., 2016) was used to identify the McProf prophage region within the 
M. chelonae genome. Phage attachment sites, attL and attR, were determined using DNA 
Master (http://cobamide2.bio.pitt.edu) to yield genome end sequences. The phage genome 
was annotated using DNA Master and the Phage Evidence Collection and Annotation Network 
(PECAAN) (https://pecaan.kbrinsgd.org/index.html). An initial auto-annotation was performed 








2003; Delcher et al., 1999). Annotation results were validated by manual inspection. Predicted 
gene functions were determined by Basic Local Alignment Search Tool (BLASTand HHpred 
analysis (Altschul et al., 1990; Soding et al., 2005). A genome map was generated in Phamerator 
using the McProf_DB database (Cresawn et al., 2011).  
2.3.4 Isolation of lysogenic strains 
 To generate BPs lysogen strains (Sampson et al., 2009), either M. chelonae (McProf) or 
M. chelonae (∆McProf) was serially diluted and plated in 4.5 mL of 7H9 top agar onto 7H10-
OAD agar plates. Plates were treated or not treated with 109 plaque forming units (PFUs) of 
BPs. Plates were then incubated for 6 d at 30˚C. Resulting colonies were grown in liquid culture 
to test for phage particle release and superinfection immunity. Efficiency of lysogeny was 
calculated by dividing the number of colonies on virus-treated plates by the number of colonies 
on non-treated plates and multiplying by 100 to yield a percentage. 
 Genomic DNA was extracted from the M. chelonae (BPs, McProf) double lysogen and 
sent to Jackson Laboratory for sequencing (Genome Technologies at Jackson Laboratory, Bar 
Harbor, ME). Whole genome libraries were prepared and sequenced on a 2x150-bp MiSeq run. 
The presence of the BPs prophage was confirmed through reads that did not align to the 
bacterial reference genome. Primers were designed to PCR amplify BPs attachment sites, attL 
and attR, to confirm prophage integration for continued cultivation of lysogen strains (Table 
2.3). Lysogen strains carrying the BPs prophage or BPs and McProf prophages are referred to as 






2.3.5 RNA isolations 
 Total RNA was extracted from four replicates of 4-mL samples of M. chelonae strains at 
an OD600 of 1.0. Samples were harvested into 6-mL of RNAProtect Bacteria Reagent (Qiagen, 
Germantown, MD) and centrifuged at 5,000 x g for 10 min. Cell pellets were resuspended in 
100 L of Tris-ethylenediaminetetraacetic acid (TE) with 20 mg mL-1 of lysozyme and incubated 
at room temperature for 40 min. Cells were treated with 700 L of RLT buffer (Qiagen) and 
transferred to 2-mL Lysing Matrix B tubes (MP Biomedicals, Irvine, CA). Samples were 
homogenized for 8 min at 50 Hz in a TissueLyser LT (Qiagen). RNA was isolated from cell lysates 
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. A first DNase 
(Qiagen) treatment was performed on the columns. RNA was eluted in 50 L of hot nuclease-
free water before undergoing a second DNase treatment using the Turbo DNA-Free Kit (Thermo 
Scientific, Waltham, MA) according to the manufacturer’s recommendations. RNA 
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Montchanin, DE). RNA quality was assessed through gel electrophoresis using the 
RNA FlashGel System (Lonza, Rockland, ME) according to the manufacturer’s instructions.  
 Experiments involving acivicin (ACI) or amikacin (AMK) treatment prior to harvest were 
completed with the following modifications to the previously described procedure. ACI-treated 
samples were grown to an OD600 of 0.7 and treated with 75 M of drug for 3 h prior to harvest.  
AMK-treated samples were grown to an OD600 of 0.9 and treated with 16.7 M of drug for 1 h 
prior to harvest. Untreated control samples were incubated for an equal amount of time prior 





2.3.6 RNAseq and read mapping  
 RNA underwent quality control analysis, library preparation, and paired end sequencing 
on an Illumina HiSeq 2500 at the Delaware Sequencing and Genotyping Center (Newark, DE). 
Samples were run on two lanes with 51-bp read lengths. Raw data files were uploaded the 
Galaxy server at usegalaxy.org (Afgan et al., 2018). Read files were concatenated, FastQC was 
used to assess quality, and reads were trimmed using Trim Galore! according to FastQC output 
(Andrew, 2010; Kreuger, 2019). Trim Galore! parameters allowed for reads with a minimum 
quality score of 30, 9-bp 5’ end trim, and 1-bp 3’ end trim to be kept. Due to incomplete rRNA 
depletion prior to sequencing, rRNA reads were computationally removed through alignment to 
the M. chelonae rRNA operon using Bowtie2 and unaligned reads were retained (Longmead et 
al., 2012). This left an average of 2,280,954 reads per sample for M. chelonae (McProf) and 
2,484,260 reads per sample for M. chelonae (BPs, McProf). The average read depth for both 
strains was 40. Reads were then quantified and aligned to the M. chelonae transcriptome 
(coding transcript fasta file obtained from GenBank) using Salmon (Patro et al., 2017). 
Alignment parameters were set to correct for the high GC content of mycobacterial genomes 
and strand specificity, with mate pair 1 coming from the reverse strand.  
  Salmon outputs were used to determine differential gene expression using the R 
statistical package, DESeq2 (Love et al., 2014). Significant regulation was identified by a Log2 
fold change (Log2FC) greater than 1 and a maximum False Discovery Rate (FDR) of 0.05. Genes 
with low expression were defined as those with less than 10 reads mapped and were 
subsequently removed. M. chelonae gene functions are poorly characterized. To overcome this, 




tuberculosis genomes using the OrthoDB pipeline (Zdobnov et al., 2014). This, in combination 
with blastP via MyocBrowser and HHpred, allowed for significantly upregulated predicted 
virulence genes in M. chelonae to be identified (Kapopoulou et al., 2011; Zimmerman et al., 
2018). 
2.3.7 cDNA synthesis and qRT-PCR 
 cDNA was synthesized in 20-L reactions containing 500 ng of total RNA using the 
qScript cDNA Supermix (Quantabio, Beverly, MA) according to the manufacturer’s 
recommendations. Reactions were run under the following thermal cycle: 5 min at 25˚C, 20 min 
at 42˚C, and 5 min at 85˚C for inactivation. Working stocks of cDNA were prepared by diluting 
samples 1:6 in 10 mM Tris.  
 Primers for quantitative real-time PCR (qRT-PCR) assays were designed to amplify a 100-
bp region with the gene of interest using Primer3 (Table 2.4). qRT-PCR assays were carried out 
in triplicate reactions in 25-L volumes containing 200 nM of each primer, 1 L of cDNA (diluted 
1:6), and PerfeCTa SYBR Green Supermix (Quantabio) according to the manufacturer’s 
instructions. Positive and no-template controls were included in each assay. Reactions were run 
using the Bio-Rad CFX96 Real-Time system (Bio-Rad Laboratories, Hercules, CA). Reactions were 
initially incubated for 3 min at 95˚C, followed by 40 cycles of 10 s at 95˚C and 30 s at 60˚C, and 
lastly a melt curve to confirm a single amplicon per target gene. Change in RNA abundance was 
normalized to M. chelonae 16S rRNA, and relative expression determined using the 2-∆∆CT 




2.3.8 Minimum inhibitory concentration assays  
 Minimum inhibitory concentration assays were performed according to Burian et al. 
(2012) and Ramon-Garcia et al. (2013). Cultures were grown in 7H9-OAD supplemented with 
0.05% Tween 80 at 30˚C with shaking and sub-cultured such that overnight incubation resulted 
in an OD600 of 0.1 – 0.3. Cultures were diluted to a density of 105 cells ml-1 and applied in 50-L 
volumes to wells of a 96-well plate containing 50 l of 7H9 media with antibiotic concentrations 
that varied by 2-fold dilutions across the plate. Amikacin (AMK) assays involving an acivicin (ACI) 
pre-treatment were carried out by diluting cultures to a density of 105 cells mL-1, treating with 
75 μM of ACI, and incubating for 3 h. Media containing varying 2-fold concentrations of 
antibiotics were applied to plates in 50-L volumes. AMK assays were performed at 
concentrations ranging from 512 – 4 g mL-1. Tobramycin (TOB) assays were performed at 
concentrations ranging from 64 – 0.5 g mL-1. Tetracycline (TET) and clarithromycin (CLA) 
assays were performed using 2-fold dilutions of antibiotic concentrations ranging from 64 – 0.5 
and 3 – 0.02 g mL-1 respectively. Clarithromycin was prepared in DMSO, and therefore DMSO 








concentration. Bacteria was applied in the absence of drugs in replicates of 16 as a control. 
Additionally, wells containing only media plus drug at each concentration were included to 
serve as an absorbance blank. Inoculated plates were sealed with porous adhesive culture plate 
films (VWR International, Radnor, PA), wrapped with parafilm and incubated at 30°C for 2 d. A 
solution of 25% Tween 80 and AlamarBlue (Bio-Rad) was added to each well in 25- and 1-L 
volumes respectively, incubated at 30˚C for 1 d, and OD measured at 570- and 600 nm. Percent 
viability of cells was calculated as the percent difference in reduction between antibiotic-
treated cells and untreated cells according to the manufacturer’s instructions. Each assay was 
replicated in a minimum of two independent experiments. 
2.4 Results 
2.4.1 Co-habitating prophages result in increased aminoglycoside antibiotic resistance in M. 
chelonae 
The wildtype M. chelonae (ATCC® 35752) carries a naturally occurring 67,657-bp 
prophage that we have named McProf. To determine how prophages impact gene expression 
and the antibiotic resistance phenotype of M. chelonae we added a second prophage. We 
identified three mycobacteriophages capable of infecting M. chelonae, Muddy, WildCat and 
BPs, of which only BPs is known to be temperate (Hatfull et al., 2010; Hatfull, 2013; Sampson et 
al., 2009). A double lysogen of M. chelonae was created from the WT M. chelonae strain using 
the cluster G mycobacteriophage, BPs (Sampson et al., 2009). BPs integrates into an attB site 
located within the 3' end of the host tRNA-Arg gene (BB28_RS01100), that is similar to the BPs 
attB site in M. smegmatis (Msmeg_6349) (Sampson et al., 2009). BPs lysogens of the M. 




Lysogens form at a higher efficiency in M. chelonae WT (25%) compared to that in M. 
smegmatis (5%) and release fewer particles into cell culture supernatant (104 – 105 PFUs mL-1 
compared to 1010 PFUs mL-1) (Sampson et al., 2009; Broussard et al., 2013).  
We tested susceptibility of M. chelonae (BPs, McProf) to aminoglycosides, AMK and 
TOB, as well as TET and CLA compared to M. chelonae (McProf) by minimum inhibitory 
concentration (MIC) assay to identify whether presence of an additional prophage alters the 
antibiotic resistance phenotype. The presence of the second prophage, BPs, significantly 
increased resistance to both aminoglycosides (Table 2.5). There was not a consistent significant 
difference in resistance to TET. As a positive control, we exposed the M. chelonae (McProf) 
strain to sub-inhibitory concentrations of acivicin (ACI), a known inducer of intrinsic resistance 
in mycobacteria (Hurst-Hess et al., 2017). As expected, ACI significantly increased the resistance 
of M. chelonae (McProf) in both the AMK and TOB assays (Table 2.5). ACI treatment did not 
significantly alter TET or CLA resistance of M. chelonae (McProf).  
 
We also determined the viability of the strains after antibiotic treatment by adding 
AlamarBlue to the wells to detect metabolic activity (Figure 2.1). There was a statistically 
 
 
Table 2.5. Minimum inhibitory concentrations for each M. chelonae strain as determined by the 





significant difference in viability between the double lysogen and WT strains treated with 64 g 
mL-1 AMK and 8 g mL-1 TOB. We noted a slight increase in viability of the WT strain at 8 g mL-
1 of TOB; however, there was no evidence of growth at this concentration of TOB. The WT 
strain treated with ACI in both the AMK and TOB assay had the highest viability at these drug 
concentrations. Some background reduction of AlamarBlue was observed for both strains at 












2.4.2 Isolation and characterization of BPs single lysogen and non-lysogen strains of M. 
chelonae  
 To better understand how the presence of the second prophage increases antibiotic 
resistance, we generated a strain of M. chelonae that contains no prophage (M. chelonae 
(McProf)) and from that, a single BPs lysogen of M. chelonae (Table 2.1). We removed the 
McProf prophage by creating a recombinant strain of M. chelonae (McProf) that overexpresses 
the McProf excise gene (gp5) from an inducible mycobacterial expression plasmid (Table 2.2) 
 
 Figure 2.1 Percent viability of M. 
chelonae (McProf) and M. chelonae 
(BPs, McProf) upon aminoglycosde 
treatment. Percent viability of M. 
chelonae carrying single prophage 
McProf (MP) and two prophages, BPs and 
McProf, in the presence of varying 
concentrations of a. AMK and b. TOB. As 
a positive control, single McProf lysogens 
were treated with 75 μM acivicin (Aci) a 
known inducer of whiB7. Graphs 
represent average values  SE of the 
mean with n=6. The optical density was 
measured at 570- and 600 nm after 
addition of 1 μL of AlamarBlue and the 
percent difference in reduction between 
antibiotic-treated cells and untreated 
cells was calculated. Mean percent 
reduction by M. chelonae that are 
statistically significant are indicated by an 
Asterix (Wilcoxon rank sum, p<0.05). 





(Parikh et al., 2013). We identified ATc-induced bacterial colonies that had an intact attB site by 
PCR amplification and sequencing (Table 2.3), indicating loss of the prophage and an active 
integrase system. To determine if McProf phage particles are released from M. chelonae 
(McProf) cells through spontaneous induction, concentrated culture supernatants were plated 
onto lawns of the newly acquired non-lysogen strain (McProf), but we were unable to detect 
plaques. PCR analysis of M. chelonae (McProf) culture supernatants also failed to detect the 
McProf attP sequence, which would have indicated the presence of either excised McProf 
genome or linear McProf genome in phage particles. It is possible that there is a mutation that 
we were not able to identify that prevents McProf from carrying out a successful lytic infection. 
Alternatively, M. chelonae may not be the natural host and McProf is capable of lytically 
infecting other mycobacterial hosts. 
The non-lysogen strain of M. chelonae (McProf) was used to isolate single lysogens of 
BPs. Although we were able to isolate BPs lysogens in the non-lysogen strain of M. chelonae, 
they are less stable than BPs lysogens formed in the WT strain (McProf) and comparable to 
lysogens formed in M. smegmatis (Sampson et al., 2009; Broussard et al., 2013). We 
determined efficiency of lysogeny to be 5% and particle release from lysogen culture 
supernatant was 1010 PFU mL-1. This contrasts an efficiency of 25% and particle release of 105 







2.4.3 Strains of M. chelonae carrying McProf demonstrate increased resistance to 
aminoglycosides 
To determine the roles of prophages BPs and McProf in the increased resistance 
observed in the double lysogen, we determined the MIC and viability of double (BPs, McProf) 
and single (BPs or McProf) M. chelonae lysogens relative to non-lysogen cells (McProf) in the 
presence of varying levels of AMK, TOB, TET and CLA (Table 2.5 and Figure 2.2).  The presence 
of the naturally occurring prophage, McProf, significantly contributes to AMK resistance in M. 
chelonae in the presence and absence of ACI treatment (Table 2.5). The WT strain carrying 
McProf alone had a higher MIC for AMK (64 g mL-1) relative to the non-lysogen strain 
(McProf) (MIC of 32 g mL-1) (Burian et al., 2012; Hurst-Hess et al., 2017). Treatment of these 
two strains with ACI increased the MIC for both strains; however, the MIC for ACI-treated WT 
(McProf) strain was two-fold higher than that of the ACI-treated non-lysogen (McProf) strain 
(Table 2.5) The presence of a second prophage, BPs, also increases resistance to AMK, with 
bacterial growth at doses as high as 64 g mL-1. Although the double lysogen had the same MIC 
as the ACI-treated WT strain (128 g mL-1) (Table 2.5), the cell viability of the ACI-treated WT 
strain was statistically higher than that of the double lysogen (Figure 2.2a). BPs alone had no 
effect on AMK resistance suggesting that BPs only increases AMK resistance through an 
interaction with the naturally occurring prophage, McProf. 
The presence of the prophages McProf and BPs also altered TOB resistance in M. 
chelonae (Table 2.5 and Figure 2.2b). The WT (McProf) strain did not have a higher TOB MIC 
than the non-lysogen strain (8 g mL-1), but in the presence of ACI, the MIC for WT (McProf) 




remained 8 g mL-1. It is possible a difference would be detected at TOB doses between 4- and 
8 g mL-1. The TOB MIC for the double lysogen (BPs, McProf) was the same as that for the ACI-
treated WT (McProf) strain; however, the viability for ACI-treated WT (McProf) strain was 
significantly higher than that of the double lysogen at 8 g mL-1 (Table 2.5 and Figure 2.2b). 
Since M. chelonae lacks erm, which confers intrinsic macrolide resistance (Nash et al., 
2009), we anticipated that there would be minimal change in CLA resistance regardless of 
prophage treatment. We observed that prophages had little effect on CLA resistance, although 
ACI treatment did increase resistance in M. chelonae (McProf) and M. chelonae (∆McProf). 
Additionally, TET resistance was largely unaltered by the presence of prophages nor by ACI 













2.4.4 Prophage McProf enhances AMK resistance in response to sub-inhibitory concentrations 
of antibiotics. 
Because the M. chelonae (McProf) strain treated with ACI had higher AMK resistance 
than the non-lysogen strain treated with ACI, we wondered if the presence of prophage McProf 
enhances the effect of sub-inhibitory concentrations of antibiotics on AMK resistance. To 
determine the interaction between ACI and the presence of one or both prophages, we treated 
all four lysogen and non-lysogen strains with sub-inhibitory concentrations of ACI and repeated 
the AMK resistance assay. The presence of McProf increases the effect of ACI on AMK 
 
Figure 2.2 Percent viability of M. 
chelonae strains upon aminoglycoside 
treatment. Percent viability of M. 
chelonae carrying single prophage 
McProf, two prophage, BPs and 
McProf, no prophage, or single BPs 
prophage in the presence of varying 
concentrations of a. AMK and b. TOB. 
As a positive control, single McProf 
lysogens and non-lysogen cultures 
were treated with 75 μM acivicin (Aci), 
a known inducer of whiB7. Graphs 
represent average values  SE of the 
mean with n=6. The optical density of 
was measured at 570- and 600 nm after 
addition of 1 μL of AlamarBlue and the 
percent difference in reduction 
between antibiotic-treated cells and 
untreated cells was calculated. Mean 
percent reduction by M. chelonae that 
are statistically significant are indicated 
by an Asterix (Wilcoxon rank sum, 





resistance compared to the non-lysogen whereas the BPs prophage alone does not (Table 2.5 
and Figure 2.3). The double lysogen treated with ACI did not have a higher MIC than the WT 
(McProf) strain treated with ACI; however, cultures of the ACI-treated double lysogen (BPs, 
McProf) did consistently have a statistically higher viability than that of ACI-treated WT 
(McProf) strain at AMK doses of 64 g mL-1.  The presence of BPs and ACI appear to interact 




Figure 2.3  Percent viability of M. chelonae strains upon AMK treatment in the presence and 
absence of ACI. Percent viability of M. chelonae carrying no prophage McProf (McMP), BPs 
prophage (Mc+BPsMP), prophage McProf (Mc+MP) or both prophage BPs and McProf 
(Mc+BPs+MP) in the presence of varying concentrations of amikacin. To determine if the presence 
of each prophage interacts with sub-inhibitory concentrations of antibiotics, each strain was 
treated or not treated with 75 μM acivicin (Aci). Graphs represent average values  SE of the mean 
with n=3. The optical density of was measured at 570- and 600 nm after the addition of 2 μL of 
AlamarBlue and the percent difference in reduction between antibiotic-treated cells and 






2.4.5 Transcriptional activator, whiB7, is upregulated in double lysogens of M. chelonae 
RNA was isolated from M. chelonae (McProf) and M. chelonae (BPs, McProf), and 
RNAseq analysis performed to determine whether the presence of a second prophage (BPs) 
influenced gene expression that could explain the increased antibiotic resistance observed in 
the double lysogen strain. Strikingly, the presence of BPs in the wildtype strain altered 
expression of 417 of 4,867 genes relative to M. chelonae (McProf). This indicated that 8.5% of 
M. chelonae genes were differentially expressed in the presence of a second prophage, 
including a variety of predicted virulence genes (Figure 2.4). 
The majority of the top-ranked genes in the double lysogen belonged to the whiB7 
regulon, genes in M. tuberculosis with functions related to antibiotic resistance and increased 
survival in macrophage (Tables 2.6 and 2.7) (Morris et al., 2005). Notably, the fifth most 
upregulated gene was identified as transcriptional activator, whiB7 (BB28_RS17590), at a fold-
change of 26.5. Analysis of the M. chelonae Whib7 peptide sequence showed characteristics of 
whiB7 genes in mycobacteria, including a conserved iron sulfur cluster binding domain and C-
 
Figure 2.4 MA plot of M. chelonae 
(BPs, McProf) gene expression. MA 
Plot presenting the relationship 
between average expression level 
(mean of normalized counts) of M. 
chelonae genes and their fold change 
(log2fold change) in the double M. 
chelonae lysogen (BPs, McProf) 
relative to the WT strain (McProf). 
Red indicates genes identified as 
differentially expressed at an FDR of 




terminal AT-hook DNA binding domain (Burian et al., 2013; Hurst-Hess et al., 2017) (Figure 2.5). 
Additionally, M. chelonae WhiB7 shares 95% peptide sequence identity with its M. abscessus 
ortholog (MAB_3508c). M. chelonae contains 103 of the 128 genes belonging to the whiB7 
regulon in M. abscessus, 30 of which are significantly upregulated in M. chelonae (BPs, McProf) 
(Hurst-Hess et al., 2017). Multiple genes from the whiB7 regulon that were upregulated have 
known roles in intrinsic antibiotic resistance, including GNAT acetyltransferases, eis1 and eis2 
(BB28_RS05390 and BB28_RS22650 respectively), multi-drug efflux transporter, tap 
(BB28_RS06750), and efflux pump, tetV (BB28_RS13560) (Table 2.7). Also included in this 
regulon are additional GNAT acetyltransferases (BB28_RS23100 and BB28_RS01940) and ABC 
transporters with ATP binding domains that likely function in drug resistance (Tables 2.6 and 
2.7). In M. abscessus and M. tuberculosis, erm is part of the whiB7 regulon and provides 
macrolide resistance but the gene is not present in the M. chelonae genome (Nash et al., 2009). 
M. chelonae lacks this whiB7 regulon gene, but it does encode a newly discovered gene in the 
whiB7 regulon, the ribosome splitting factor hflX (MAB_3042c), which is reported to contribute 
to macrolide resistance in M. abscessus (Nash et al., 2009; Rudra et al., 2020). Expression of the 
M. chelonae hflX was slightly elevated in double lysogens relative to the WT strain (McProf) 
(BB28_RS14985; LogFC=2.8, FDR=8.4-33) but this did not result in significant changes in CLA 
resistance in the double lysogen (Table 2.7). An additional 25 whiB7 regulon genes were 




The most highly regulated gene, with a 99-fold increase in expression, was annotated as 
a flotillin protein with no known function (BB28_RS01845) (log2FC = 6.6, FDR = 6.4–124) (Table 
2.6).  Several of the most down regulated genes in the lysogen include a padR-family 
transcription factor (BB28_RS01835, Log2FC= -8.3, FDR = 1.4–10) and genes involved in glycerol 
uptake (glpF, BB28_RS01835, Log2FC= -6.2, FDR = 4.5–06) and metabolism (glpK, BB28_RS01840, 
Log2FC= -9.0, FDR = 1.1–12) (Table 2.6) (Ehrt et al., 2005). RNAseq data were validated by 
performing qRT-PCR on two independent sets of RNA measuring relative expression of 
upregulated (whiB7 and tap) and downregulated (glycerol kinase (glpK)) genes as indicated by 








Figure 2.5 WhiB7 protein alignment. Clustal Omega alignment of the protein coding sequence 
for WhiB7 in M. tuberculosis (MTb), M. smegmatis (MSMEG), M. abscessus (MAB), and M. 










Figure 2.6 qRT-PCR verification of 
RNAseq data. The average relative 
expression levels of whiB7, tap, and glpK 
in M. chelonae (BPs, McProf) (green bars) 
relative to M. chelonae (McProf) (blue 
bars) measured by SYBR Green qRT-PCR. 
Genes were selected based on up- or 
downregulation in RNAseq data to 
validate results. RNA was isolated in 
triplicate from cells at an OD600 of 1.0. 
Graphs represent average values ± 
standard error of the mean with n=3 and 
are representative of two independent 
trials. Means with different letters are 














Table 2.6 Top 20 upregulated and downregulated genes in M. chelonae (BPs, McProf) 






2.4.6 Upregulation of whiB7 only occurs in M. chelonae (BPs, McProf) 
To determine how the presence and absence of each prophage impacts whiB7 
expression, RNA was isolated from each strain at an OD600 of 1.0 and whiB7 mRNA levels were 










(McProf) and compared to that of the WT strain (McProf) (Figure 2.7). Although whiB7 
expression was slightly elevated in the non-lysogen (2-fold) and BPs single lysogen (4-fold) 
strains relative to the WT strain (McProf), the dramatic increase in whiB7 expression (~40-fold) 
only occurred in M. chelonae carrying both prophages (BPs, McProf). The elevated whiB7 
expression occurred in the absence of known inducers of whiB7, such as ACI, which suggests 
BPs-encoded gene products interact with prophage McProf, resulting in whiB7 induction. The 
elevated expression of whiB7 in the double lysogen likely explains the increased resistance to 






Figure 2.7 qRT-PCR analysis 
of whiB7 expression in M. 
chelonae strains. The average 
relative expression levels of 
whiB7 in M. chelonae carrying 
McProf alone, BPs and 
McProf, no prophage, and BPs 
alone as measured with SYBR 
Green qRT-PCR. Cultures 
were grown to an OD600 of 1.0 
before harvesting RNA in 
triplicate. Graphs represent 
average values ± standard 
error of the mean with n=3 
and are representative of two 
independent trials. Means 
with different letters are 






2.4.7 Sub-inhibitory concentrations of ACI, but not AMK, increase whiB7 expression in M. 
chelonae (BPs, McProf) 
We were surprised that the M. chelonae (McProf) strain had the lowest expression of 
whiB7 expression among the four strains given that it had higher AMK resistance, both in the 
presence and absence of ACI, than the two strains that lack McProf. We reasoned this may be 
due to whiB7-independent intrinsic resistance, such as cell wall permeability, and/or whiB7 
induction in the presence of AMK, which is a more potent inducer of whiB7 than ACI (Hurst-
Hess et al., 2017). Likewise, we wondered if the heightened viability observed in the single and 
double McProf lysogen strains in the presence of AMK and ACI was due to increased whiB7 
expression. To assess this, we measured whiB7 expression in double, single, and non-lysogen 
strains following a 3-h treatment with 75 M ACI or 1-h treatment with 16.7 M AMK (Figures 
2.8 and 2.9).  
ACI treatment resulted in increased whiB7 expression in all four strains relative to 
untreated strains (Figure 2.8). Expression of whiB7 was highest in the double lysogen strain 
(BPs, McProf) treated with ACI which correlates with the observed AMK resistance of this 
strain. whiB7 expression in the single and non-lysogen strain increased with ACI treatment; 
however, the relative levels of whiB7 expression did not correlate with AMK resistance (Figure 
2.3a).  Although the fold-increase of whiB7 in ACI-treated strains relative to control strains was 
highest in the WT strain (McProf) (9.5-fold) whiB7 was lower than that of the ACI-treated BPs 








Strains that lack the McProf prophage had the greatest increase in whiB7 expression in 
response to AMK treatment. The non-lysogen and BPs single lysogen had 28- and 7-fold 
increases in whiB7 expression in response to AMK treatment, respectively (Figure 2.9). AMK 
had less of an effect on whiB7 expression in strains carrying McProf. AMK treatment resulted in 
a 3.5-fold increase in whiB7 expression in the single McProf lysogen and no significant increase 
in whiB7 expression in the double lysogen. It’s possible that AMK doesn’t result in strong 
induction of whiB7 expression in the McProf-carrying strains due to cell wall permeability 
 
Figure 2.8 qRT-PCR analysis of 
whiB7 expression in M. chelonae 
strains in the presence and 
absence of ACI treatment. The 
average relative expression levels 
of whiB7 in M. chelonae carrying 
McProf alone, no prophage, BPs 
alone, or BPs and McProf as 
measured with SYBR Green qRT-
PCR. RNA was harvested in 
triplicate from strains grown to 
an OD600 of 0.7 before treating or 
not treating with 75 μM ACI and 
incubating for an additional 3 h. 
The culture OD600 at time of 
harvest was close to 1 but 
differed slightly for each strain 
and treatment.  Graphs represent 
mean ± SE with n=3. Letters 
represent statistically significant 






and/or efflux, and if so, this could also explain the AMK-resistant phenotypes observed in the 
single McProf and double lysogen strains. 
2.4.8 Characterization of the McProf prophage 
The McProf genome was characterized to uncover potential interactions between the 
naturally occurring prophage and BPs in M. chelonae to increase whiB7 expression and 
antibiotic resistance. McProf is 67,657 bp in length, spanning coordinates 1,521,426 – 
1,589,648 in M. chelonae CCUG 47445. The genome encodes 98 putative genes, no tRNAs, and 
has been annotated in its prophage format with the first gene located immediately adjacent to 
attL (Figure 2.10). The McProf prophage is integrated into a leftward oriented tRNA-Lys 
 
Figure 2.9 qRT-PCR analysis of 
whiB7 expression in M. 
chelonae strains in the 
presence and absence of AMK 
treatment. The average 
relative expression levels of 
whiB7 in M. chelonae carrying 
McProf alone, no prophage, 
BPs alone, or BPs and McProf 
as measured with SYBR Green  
qRT-PCR. RNA was harvested 
in triplicate from strains 
grown to an OD600 of 0.9 
before treating or not treating 
with 16.7 μM AMK and 
incubated for an additional 1 
h.  Graphs represent mean ± 
SE with n=3. Letters represent 
statistically significant 





(BB28_RS07905) and is flanked by 45-bp attachment sites, attL and attR (5’- 
TGCGCCGTCAGGGGCTCGAACCCCGGACCCGCTGATTAAGAGTCA-3’).  
 Gp1 encodes a rightward transcribed tyrosine integrase, followed by a gene of unknown 
function (gp2) and the predicted immunity repressor (gp3). Gp3 shares high sequence similarity 
with immunity repressors identified in other mycobacteriophages, such as singleton DS6A, and 
cluster K12 phages, DismalFunk, DismalStressor, Findley, Milly, and Marcoliusprime (Russel and 
Hatfull, 2016). Gp4 and gp5 encode Cro (control of repressor’s operator) and excise respectively 
and contain helix-turn-helix (HTH) DNA binding motifs characteristic of these genes. The McProf 
genome follows the typical synteny of bacteriophage with genes involved in DNA replication 
and metabolism oriented downstream of the integration cassette. Structural genes span gp51 – 
82 and include a lysis cassette encoding lysin A, lysin B, and holin (gp76 -78 respectively). 
Between the structural genes and the attR site is a region of genes that are typically expressed 
during lysogeny, although many of these genes do not have a predicted function in McProf 
(Dedrick et al., 2017). Genes within this region with predicted functions include an ADP-ribosyl 
glycosylhydrolase (gp86), a HTH DNA binding protein (gp89), a membrane protein (gp90), an  





Of interest is the polymorphic toxin (PT) cassette on the rightmost arm of the McProf 
genome, as it encodes proteins that are likely secreted by a mycobacterial Type 7 secretion 
system (T7SS) expressed by M. chelonae (Esx3 or Esx4). HHpred analysis of gp98 suggests that it 
encodes a 105-amino acid product consistent with T7SS proteins based on helical domains with 
high similarity to characteristic WXG-100 motifs (Pallen, 2002). However, gp98 includes a SAG 
motif that is slightly different from the conserved WXG motif. Gp97 appears to encode a 732-
amino acid polymorphic toxin. The C-terminus includes a toxin_43 motif (PF15604.6) with high 
sequence similarity to Type 6 secretion system (T6SS) polymorphic toxin, TdeI. This toxin was 
identified in Agrobacterium tumefaciens (Atu4350) and belongs to a family of proteins 
exhibiting DNase activity characterized by a conserved HxxD catalytic domain in the C-terminus 
(Ma et al., 2014). In addition, gp97 contains a WXG-100 motif in the N-terminus and a likely 
 
Figure 2.10 Phamerator map of the McProf genome. The coordinates of the McProf genome 
are represented by the ruler. Genes are shown as colored boxes above (transcribed 
rightwards) or below (transcribed leftward) the ruler. The map was generated using 





T7SS secretion signal, YxxxD/E, in the C-terminus (Daleke et al., 2012). Gp96 encodes a 
predicted 216-amino acid Tdi-like immunity protein, which are known to be paired with Tdi 
toxins to neutralize its activity. Gp96 includes the conserved domains characteristic of Tdi 
proteins, GAD and DUF1851 (Figure 2.11) (Ma et al., 2014).  
 
2.4.9 Lysogenic gene expression profiles from the BPs and McProf prophage genomes. 
To determine if the presence of BPs alters gene expression from the McProf prophage 
genome, differential expression of McProf genes was examined between the WT strain 
(McProf) and the double lysogen (BPs, McProf). None of the expressed McProf genes were 
significantly differentially expressed in the presence of the BPs prophage (FC>1.99 and 
FDR<0.05). Because there was no difference in expression profiles, we present below the 
expression profile of only the McProf prophage from the M. chelonae WT (McProf) strain 
(Figure 2.12b). 
The immunity repressors from both the BPs (gp33) and McProf (gp3) genomes are 
highly expressed during lysogeny of M. chelonae (Figure 2.12). The BPs genome also expresses, 
gp58, a gene of unknown function that is part of a mycobacteriophage mobile element 
 
 
Figure 2.11 McProf ESX-like polymorphic toxin cassette. Graphical domain 





(MPME1) (Figure 2.12a) (Sampson et al., 2009). There are an additional 15 genes expressed at 
varying levels from the McProf genome (Figure 2.12b). The integrase (gp1) is expressed at low 
levels and is adjacent to a moderately expressed gene of no known function (gp2). There are 
three reverse oriented genes, gp48 – 50, located between the HNH endonuclease (gp47) and 
the small subunit terminase (gp51) and a small reverse oriented gene (gp56) adjacent to the 
scaffolding protein with moderately and low expression, respectively. We were not able to 
determine functions for these genes; however, gp46 and gp47 do have predicted membrane 
domains. The remaining genes expressed from the McProf prophage genome are located 
between the structural genes and attR and many do not have predicted gene functions, 
including the most highly expressed McProf gene, gp84. There is also strong expression from 
the gene cassette containing the putative WXG-100 family polymorphic toxin and immunity 
protein (gp96 – 98). None of the expressed McProf genes were significantly differentially 














Cases of NTM infections have been on the rise in recent decades (Johansen et al., 2020). 
M. abscessus, a causative agent of pulmonary infections, has become a major health concern, 
especially for immunocompromised individuals, due to extreme antibiotic resistance (Johansen 
et al., 2020). Frontline antibiotics used to treat M. abscessus infections include CLA and AMK. 
However, the bacteria encounter a drug gradient in tissues and often develop resistance during 
the course of treatment (Guo et al., 2020). In many cases, resistance is caused by mutations in 
 
Figure 2.12 Lysogenic gene expression profiles of BPs and McProf.  Lysogenic gene 
expression profiles of prophages a. BPs and b. McProf from the M. chelonae WT strain. 
RNAseq profiles are shown for forward (blue) and reverse (red) DNA strands. Note that 
in a. the sequence reads are mapped to the viral BPs genome rather than prophage 
genome whereas in b. the sequence reads are mapped to the McProf prophage genome. 
The number of reads mapped are on the y-axis and the genome maps are shown below. 
Genes expressed from the McProf prophage genome in the double lysogen were not 






16S or 23S rRNA which confer resistance to AMK and CLA respectively, but do not account for 
extensively resistant phenotypes in all isolates (Nessar et al., 2012). Additionally, induction of 
the whiB7 regulon contributes to increased resistance and whiB7 expression is elevated in 
extensively resistant strains of M. abscessus compared to those susceptible to treatment (Guo 
et al., 2020). Elucidating the mechanisms that trigger upregulation of whiB7 could lead to more 
effective therapies for extensively resistant mycobacterial infections.  
 We have demonstrated that the presence of prophages in mycobacteria contribute to 
increased AMK and TOB resistance (Table 2.5 and Figure 2.4). This is similar to the effect 
previously described in E. coli where strains lacking prophages were more sensitive to -lactam 
(Wang et al., 2010). Interestingly, the McProf prophage alone appears to play a more significant 
role, but addition of second prophage (BPs) amplifies the effect of McProf on antibiotic 
resistance. Strains of M. chelonae carrying BPs only or no prophage were more susceptible to 
AMK relative to those carrying McProf. Additionally, ACI treatment increased AMK and TOB 
resistance in all strains, which makes sense because ribosome-targeting antibiotics induce 
whiB7 expression and therefore increase intrinsic antibiotic resistance (Table 2.5 and Figure 
2.5) (Morris et al., 2005; Burian et al., 2012). However, this effect was elevated in M. chelonae 
(McProf) in AMK assays and further enhanced by presence of BPs compared to M. chelonae 
(∆McProf), indicating that McProf plays a substantial role in mediating AMK resistance.  
 The dramatically higher whiB7 expression in the strain carrying both prophages (BPs, 
McProf) likely contributes to the heightened AMK and TOB resistance observed in the double 
lysogen (Figures 2.7 and 2.9; Tables 2.6 and 2.7). We observed high whiB7 expression in the 




revealing prophage as a novel mechanism of inducing whiB7 expression and intrinsic antibiotic 
resistance. Also upregulated in the double lysogen are whiB7 regulon genes that can explain the 
increased resistance to aminoglycosides AMK and TOB (Pryjma et al, 2017). The GNAT 
acetyltransferase, eis2, and tap, a multidrug efflux pump, were each upregulated ~10-fold in 
the double lysogen and confer resistance to aminoglycosides (Hurst-Hess et al., 2017; Ainsa et 
al., 1998; Chen et al., 2012). 2-N-acetyltransferase AAC(2) also contributes to resistance to 
TOB and AMK, however this gene (BB28_RS22055) was not significantly upregulated in our data 
set (Luthra et al., 2018). It is possible that other N-acetyltransferases (BB28_RS23100, 
BB28_RS01940, BB28_RS14560), aminoglycoside phosphotransferases (BB28_RS12685), or 
potential efflux pumps (BB28_11540) upregulated in our dataset contributed to AMK and TOB 
resistance of the double lysogen (Table 2.7). Tap, along with TetV (BB28_RS13560) target 
tetracycline efflux, however, we did not consistently see an increase in TET resistance across all 
our MIC trials (De Rossi et al., 2002; De Rossi et al., 1998). Although M. chelonae lacks an erm 
gene, there was a slight elevation in the whiB7 regulon gene, hflx, but this did not result in a 
significant change in CLA resistance (Rudra et al., 2020). 
  There are likely other mechanisms of intrinsic resistance at play that contribute to 
increased aminoglycoside resistance in McProf-carrying strains. Although whiB7 expression was 
highest in the double lysogen (BPs, McProf) treated with ACI among the four strains, whiB7 
expression levels in the single McProf strain did not correlate with its relative AMK resistance 
among the four strains. AMK is also a potent inducer of whiB7 expression in mycobacteria, but 
surprisingly, AMK had little to no effect on whiB7 expression in strains carrying McProf (Hurst-




McProf. It is possible that McProf somehow alters cell wall permeability. A decrease in 
permeability would likely contribute to the observed AMK resistance in these strains, and 
further investigating this potential effect will be important to understanding the impact of 
prophage on drug resistance.  
 We do not yet know how phage-encoded proteins from the two prophages, BPs and 
McProf, interact to alter whiB7 expression in the double lysogen strain. The McProf genome 
appears to only express genes through lysogenic infection of M. chelonae, whereas BPs can 
carry out lysogenic and lytic infection (via induction) in a population of double lysogen cells. It’s 
therefore possible that either lytic or lysogenic gene expression from BPs interacts with McProf 
through an unknown mechanism to alter whiB7 expression. Alternately, the McProf-encoded 
ESX-like polymorphic toxin cassette should be investigated for contributions to altering whiB7 
expression. Activated toxin systems could potentially act as a trigger to the WhiB7 stress 
response. Sub-inhibitory concentrations of antibiotics and BPs phage infection both enhanced 
antibiotic resistance in M. chelonae in the presence of prophage McProf (Figures 2.1 and 2.3), 
conditions also known to activate toxin systems (Kumar et al., 2019; LeRoux et al., 2015; 
Slayden et al., 2018; Wang et al., 2011). Toxin/antitoxin (TA) systems are also known to function 
as stress response modules and regulators of adaptive responses to stresses associated with 
host environment and drug treatment (Slayden et al., 2018). TA systems also stabilize 
replicative elements (e.g. plasmids and prophage) and defend against phage lytic infection (Yao 
et al., 2018; Fraikin et al., 2020; Wozniak et al., 2009). The increased stability of the BPs 




(McProf) and its reported instability in M. smegmatis strains suggests that the polymorphic 
toxin system encoded by McProf is active (Sampson et al., 2009; Broussard et al., 2013).   
Our novel research findings indicate that prophage could be drivers of important 
intrinsic antibiotic resistance genes in response to stresses. To determine the mechanism by 
which phage alter intrinsic antibiotic resistance in mycobacteria, we are exploring the function 





















CHARACTERIZING THE ROLE OF PHAGE BPS GENE PRODUCTS IN INCREASED WHIB7 
EXPRESSION IN STRAINS OF MYCOBACTERIUM CHELONAE CARRYING MCPROF 
 
3.1 Chapter Summary 
 Mycobacterium abscessus is a nontuberculous pathogen associated with lung and 
disseminated infection and is becoming a major public health concern (Griffith, 2019). 
Emergence of extensively drug resistant strains has hindered effective treatment (Griffith, 
2019). Common among these strains are integrated bacteriophage genomes (prophage) that 
are hypothesized to contribute to mycobacterial fitness and virulence (Fan et al., 2015). How 
prophage impact bacterial fitness, particularly when they don’t encode an obvious virulence 
factor, is not understood. 
 We are investigating the role of prophage in mycobacterial fitness and antibiotic 
resistance in M. chelonae, a member of the M. abscessus/M. chelonae complex which carries a 
naturally occurring prophage, McProf. Previous RNAseq analysis of M. chelonae (McProf) 
carrying a second prophage, BPs, showed drastic changes in bacterial gene expression relative 
to the wildtype strain, as well as BPs single lysogen and non-lysogen strains. This included 
significant upregulation of whiB7, a conserved mycobacterial transcriptional activator that 
regulates genes associated with antibiotic resistance and stress adaptation (Morris et al. 2005; 
Burian et al., 2012). To investigate the role of BPs on whiB7 expression in double lysogens (M. 
chelonae (BPs, McProf)), we constructed recombinant strains of M. chelonae (McProf) to 




demonstrated no significant impact on whiB7 expression, indicating that BPs lysogenic gene 
products alone do not contribute to increased whiB7 expression observed in M. chelonae (BPs, 
McProf). Taken together, these data suggest that altered expression of whiB7 may be caused by 
an alternative interaction between BPs and the naturally occurring prophage, McProf. 
Identifying prophage-encoded factors that contribute to fitness will be important in developing 
alternative treatment strategies for mycobacterial infections. 
3.2 Introduction  
 Non-tuberculous mycobacterial infections are becoming increasingly prevalent and are 
difficult to treat due to high levels of intrinsic antibiotic resistance (Nessar et al., 2012). 
Emergence of extensively resistant strains presents a new challenge where infections are 
essentially impossible to eradicate, especially in the case of Mycobacterium abscessus 
(Johansen et al., 2020). While mutations in drug targets have explained extensive resistance in 
some M. abscessus isolates, it does not account for all of these phenotypes (Guo et al., 2020). 
All extensively resistant isolates, however, have elevated expression of the conserved 
mycobacterial transcriptional activator, whiB7 (Griffith, 2019; Guo et al., 2020).  
 whiB7 regulates genes involved in intrinsic antibiotic resistance and stress adaptation 
and is typically upregulated under stress conditions such as drug treatment and the intracellular 
environment of macrophage (Morris et al., 2005; Burian et al., 2012). However, the cause of 
this increased expression in extensively resistant strains in the absence of environmental 
triggers remains unknown. Recently, we demonstrated that integrated viral genomes 




 Most pathogenic bacteria carry prophage that are known to contribute to fitness and 
antibiotic resistance. For example, the Pf4 prophage in Pseudomonas aeruginosa influences 
biofilm formation which allows for drug tolerance (Rice et al., 2009; Wang et al., 2016). 
Macrolide resistance is observed in multi-drug resistant strains of Streptococcus pyogenes that 
is conferred by a prophage-encoded erythromycin resistance, or erm gene (Hyder and 
Streitfeld, 1978; Wang et al., 2016). The majority of sequenced pathogenic mycobacteria to 
date carry at least one prophage or prophage-like element (Bibb and Hatfull, 2002; Fan et al., 
2014; Dedrick et al., 2021).  Recent efforts in sequencing clinical M. abscessus isolates showed 
that 85% of strains carry at least one prophage (Dedrick et al., 2021). Dedrick et al. (2021) 
identified 67 novel prophage sequences that have been assigned to 17 Mab clusters (A – Q) 
based on >35% shared gene content. However, their role on fitness and virulence has not been 
explored.  
 M. chelonae, an opportunistic pathogen belonging to the M. abscessus/M. chelonae 
complex, serves as an ideal model for studying the impact of prophage and mechanisms of 
antibiotic resistance in pathogenic mycobacteria. In addition to sharing >80% sequence identity 
with M. abscessus, M. chelonae also encodes a whiB7 regulon that shares 103 of the 128 genes 
identified in the M. abscessus regulon (Hurst-Hess et al., 2017). Additionally, it carries a novel 
cluster MabR prophage (McProf) that is closely related to prophages identified in the genomes 
of clinical M. abscessus strains (Molloy, Unpublished). Our previous work demonstrated that 
the addition of a second prophage, BPs, to wildtype M. chelonae (BPs, McProf) to form a double 
lysogen increased both whiB7 expression and resistance to aminoglycosides, amikacin and 




single lysogen and non-lysogen strains of M. chelonae) suggesting an interaction between the 
two prophages occurs to increase whiB7 expression (Cushman et al., 2021). How the two 
prophages interact to alter gene expression is not understood. It appears that McProf is unable 
to carry out a successful lytic infection in M. chelonae, and therefore only exists in its prophage 
form. Conversely, there is evidence of both lytic and lysogenic BPs growth in cultures of double 
lysogen cells. It is possible that either lytic or lysogenic BPs gene expression in the presence of 
McProf is responsible for changes in gene expression. However, the BPs prophage is extremely 
stable in the presence of the prophage McProf, and the majority of cells carry BPs in its 
prophage form in a double lysogen culture.  
 Here we explore the role of the BPs lysogenic gene products on whiB7 expression in the 
presence of prophage McProf. We have identified the lysogenic gene expression profile for BPs 
in double lysogens of M. chelonae (BPs, McProf) and generated recombinant strains of M. 
chelonae (McProf) to determine the impact of individual BPs lysogenic gene products on whiB7 
expression. 
3.3 Materials and Methods 
3.3.1 Bacterial and viral strains 
Mycobacterium chelonae (ATCC®35752, American Type Culture Collection, Manassas, VA) 
was grown in liquid Middlebrook 7H9 broth (BD, Sparks, MD) supplemented with 10% oleic 
acid, albumin, dextrose (OAD) and 0.05% Tween 80 at 30˚C with shaking at 230 RPM. The 
wildtype strain of M. chelonae carries a naturally occurring prophage, McProf, and will be 
referred to as M. chelonae (McProf). M. smegmatis MC2155 (ATCC®700084, American Type 




37˚C with shaking. Kanamycin (KAN) was used as a selective measure for recombinant strains at 
a concentration of 250 μg mL-1 in liquid and solid media. Competent E. coli DH5  cells were 
prepared by New England Biolabs, (Ipswich, MA) and grown in Luria broth base, Miller (BD) 
supplemented with 50 μg mL-1 of KAN at 37˚C with shaking at 230 RPM for propagation of 
plasmids. Bacterial strains used in this work are listed in Table 3.1. Plasmids used in this study 
are listed in Table 3.2.   
Mycobacteriophages BPs and CLED96 were obtained from the Hatfull Laboratory (Sampson 
et al., 2009) and cultivated by plaque assay using M. chelonae (McProf) or M. smegmatis 
MC2155. Serially diluted phage samples were incubated for 15 min at room temperature in 0.5-
ml aliquots of late log phase bacteria. Aliquots were plated in 4.5 ml of 0.45% 7H9 top agar 
onto 7H10 agar plates. High titer phage lysate stocks were generated by flooding bacterial 
lawns with nearly confluent lysis with phage buffer (10 mM Tris/HCl pH 7.5, 10 mM MgSO4, 1 































3.3.2 Isolation of lysogenic strains 
To generate BPs and CLED96 lysogen strains, M. chelonae (McProf) was serially diluted 
and plated in 4.5 mL of 7H9 top agar onto 7H10-OAD agar plates. One set of plates was treated 
with 109 plaque forming units (PFUs) of BPs or CLED96, while the second set was untreated. 
Plates were then incubated for 6 d at 30˚C. Resulting colonies were grown in liquid culture to 
test for phage particle release and superinfection immunity. Efficiency of lysogeny was 
calculated by dividing the number of colonies on virus-treated plates by the number of colonies 








 Genomic DNA was extracted from the M. chelonae (BPs, McProf) double lysogen and 
sent to Jackson Laboratory for sequencing (Genome Technologies at Jackson Laboratory, Bar 
Harbor, ME). Whole genome libraries were prepared and sequenced on a 2x150-bp MiSeq run. 
The presence of the BPs prophage was confirmed through reads that did not align to the 
bacterial reference genome. Primers were designed to PCR amplify BPs attachment sites, attL 
and attR, to confirm prophage integration for continued cultivation of lysogen strains (Table 
3.3). This same PCR assay confirmed presence of the CLED96 prophage as well. The lysogen 
strains carrying the BPs and McProf or CLED96 and McProf prophages are referred to as M. 














































3.3.3 Construction of recombinant strains  
Mycobacterial expression vector, pMO21, provided by the Hatfull Laboratory, carries a 
phage encoded ParABS system and kanamycin resistance gene, but lacks a promoter region. 
The plasmid was modified to include a constitutive Hsp60 promoter and is referred to as 
pMOHsp. pMO21 was digested with NotI per the manufacturer’s recommendations (NEB) to 
linearize the vector. Linearized vector was purified on a DNA clean-up column (NEB). Digested 
pMO21 underwent a Gibson Assembly (NEB) reaction with a 445-bp G-block (Integrated DNA 
Technologies, Coralville, IA) carrying an hsp60 promoter region and flanking regions 
complementary to the plasmid ends to generate a vector with a constitutive promoter. 
Products were transformed into competent E. coli cells (NEB) and plated onto L agar 
supplemented with 50 µg mL-1 kanamycin (KAN).  pMOHsp was linearized with KpnI according 
to the manufacturer’s recommendations (NEB). Expression vectors were constructed using 432-
bp and 499-bp G-blocks (IDT) that each included 30 bp of plasmid backbone sequence that flank 
the KpnI insertion site at the 5’ and 3’ end of the G-blocks and an internal sequence that 
corresponds to the BPs gp58 ORF (39,973 − 40,308 bp) or the entire MPME1 sequence (39,824 
− 40,308 bp) (Table 3.3). The BPs gp58 ORF G-block was inserted into pMOHsp to generate an 
overexpression vector, while the MPME1 sequence was inserted into pMO21 and expressed 
from its native promoter. Similarly, gp5 was PCR amplified to include extensions that 
correspond to 30 bp of flanking sequence to the pMOHsp KpnI insertion site. Fragments were 
assembled into the vector via Gibson Assembly (NEB) and transformed into competent E. coli 




harvested from transformants were confirmed by PCR (Table 3.3) and are referred to as 
pMOgp5, pMOgp57-58, and pMOgp58.  
Bacterial expression vector, pMH94 (Lee et al., 1991) is integration-dependent and 
includes an L5 integration cassette and kanamycin resistance gene. The vector was digested 
with SalI per the manufacturer’s recommendation (NEB) in order to linearize the vector and 
remove the L5 integrase cassette. Fragments were separated on a FlashGel Recovery Cassette 
according to the manufacturer’s instructions (Lonza, Rockland, ME) and a 4,136 bp fragment 
was recovered. The BPs integrase (gp32), attP site, immunity repressor (gp33) and upstream 
intergenic region including the native promoter (29,521 − 27,696 bp) were PCR amplified with 
primers that include 30-bp 5’ extensions that correspond to the ends of SalI-digested pMH94. 
Similarly, a control vector was constructed by PCR amplifying the BPs integrase, the attP site, 
and the 3’ end of gp33 (29,270 − 27,696 bp) to prevent a functional immunity repressor from 
being expressed. Each insert was cloned into SalI-digested pMH94 by Gibson cloning, as 
described above, to generate pMHIR and pMHIattP (Table 3.2). 
All vectors were electroporated into competent M. chelonae strains according to de 
Moura et al. (2014). Briefly, electrocompetent M. chelonae cells were prepared by washing with 
ice-cold 10% glycerol four times. Plasmid DNA in 500 ng quantities were electroporated with 
100 µL of electrocompetent M. chelonae in 0.2-cm gap cuvettes. A sample of electrocompetent 
cells lacking plasmid DNA served as a negative control. Electroporation was carried out in a 
single pulse at 2.5 kV, 25 mF, 1,000 Ω. Cells were suspended in 900 µL of room-temperature 
7H9-OAD and incubated at 30˚C with shaking for 4 h prior to plating on 7H10-OAD agar plates 




of the plasmid (Table 3.3). Because our work involved analysis of gene expression, specifically 
whiB7, plasmids were not maintained with antibiotic selection following generation of 
recombinant strains. pMOHsp, pMO21, and their respective subclones were maintained by a 
bacterial partitioning system encoded by the vector. pMH94 was maintained by integration into 
the L5 attachment site and pMHIR and pMHIattP were maintained by integration into the BPs 
attachment site. Successful expression of target genes in recombinant strains was confirmed by 
qRT-PCR. 
3.3.4 RNA isolations  
 Total RNA was extracted from four replicates of 4-mL samples of M. chelonae strains at 
an OD600 of 1.0. Samples were harvested into 6-mL of RNAProtect Bacteria Reagent (Qiagen, 
Germantown, MD) and centrifuged at 5,000 x g for 10 min. Cell pellets were resuspended in 
100 L of Tris-ethylenediaminetetraacetic acid (TE) with 20 mg mL-1 of lysozyme and incubated 
at room temperature for 40 min. Cells were treated with 700 L of RLT buffer (Qiagen) and 
transferred to 2-mL Lysing Matrix B tubes (MP Biomedicals, Irvine, CA). Samples were 
homogenized for 8 min at 50 Hz in a TissueLyser LT (Qiagen). RNA was isolated from cell lysates 
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. A first DNase 
(Qiagen) treatment was performed on the columns. RNA was eluted in 50 L of hot nuclease-
free water before undergoing a second DNase treatment using the Turbo DNA-Free Kit (Thermo 
Scientific, Waltham, MA) according to the manufacturer’s recommendations. RNA 
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Montchanin, DE). RNA quality was assessed through gel electrophoresis using the 




3.3.5 cDNA synthesis and qRT-PCR  
cDNA was synthesized in 20-L reactions containing 500 ng of total RNA using the 
qScript cDNA Supermix (Quantabio, Beverly, MA) according to the manufacturer’s 
recommendations. Reactions were run under the following thermal cycle: 5 min at 25˚C, 20 min 
at 42˚C, and 5 min at 85˚C for inactivation. Working stocks of cDNA were prepared by diluting 
samples 1:6 in 10 mM Tris.  
 Primers for quantitative real-time PCR (qRT-PCR) assays were designed to amplify a 100-
bp region with the gene of interest using Primer3 (Table 3.4). qRT-PCR assays were carried out 
in triplicate reactions in 25-L volumes containing 200 nM of each primer, 1 L of cDNA (diluted 
1:6), and PerfeCTa SYBR Green Supermix (Quantabio) according to the manufacturer’s 
instructions. Positive and no-template controls were included in each assay. Reactions were run 
using the Bio-Rad CFX96 Real-Time system (Bio-Rad Laboratories, Hercules, CA). Reactions were 
initially incubated for 3 min at 95˚C, followed by 40 cycles of 10 s at 95˚C and 30 s at 60˚C, and 
lastly a melt curve to confirm a single amplicon per target gene. Change in RNA abundance was 
normalized to M. chelonae 16S rRNA, and relative expression determined using the 2-∆∆CT 











3.4 Results  
3.4.1 Organization of the BPs and CLED96 genomes and gene expression profile of BPs in the 
M. chelonae double lysogen (BPs, McProf) 
BPs is a temperate mycobacteriophage belonging to subcluster G1. Its genome spans 
41,901 bp with a GC content of 66.6%, and it encodes 63 putative genes (Sampson et al., 2009). 
BPs is closely related to G1 phage, CLED96, which is nearly identical in sequence to BPs (a four-
nucleotide difference) aside from lacking mycobacteriophage mobile element 1 (MPME1) 
(Sampson et al., 2009). BPs has a broad host range and is able to infect multiple mycobacterial 
species including M. smegmatis, M. tuberculosis, M. abscessus, and M. chelonae (Jacobs-Sera et 
al., 2012).  
Genome organization follows the typical synteny of bacteriophage in linear orientation 
with structural and assembly components on the left arm followed by lysis and integration 









2009) (Figure 3.2). The lysis cassette includes gp27, gp28, and gp29, and encodes lysin A, lysin 
B, and holin, respectively. The integration cassette is downstream of this region, separated by 
two genes of unknown function. Gp32, gp33, and gp34 encode a tyrosine integrase, immunity 
repressor, and Cro, respectively. Lysogeny maintenance and the stability of cluster G immunity 
repressors is dependent upon phage genome integration into the bacterial genome (Broussard 
et al., 2013). The phage attachment site (attP) is located on the 3’ end of the immunity 
repressor (Broussard et al., 2013; Villanueva et al., 2015) (Figure 3.1). Therefore, integration of 
the BPs genome into its host truncates the immunity repressor at the 3’ end (Villanueva et al., 
2015). This truncation results in translation of a functional repressor protein lacking the ssrA-
like tag encoded on the C-terminus of gp33 that targets the protein for degradation (Villanueva 
















Both BPs and CLED96 are able to form stable lysogens in M. chelonae WT. The efficiency 
of lysogeny was 25%, a significant increase compared to lysogens of M. smegmatis where 
efficiency is closer to 5% (Broussard et al., 2013). In addition, particle release from BPs lysogens 
of M. chelonae is low relative to BPs lysogens of M. smegmatis, measured at approximately 105 
PFU mL-1 in M. chelonae lysogens compared to about 1010 PFU mL-1 in M. smegmatis lysogens. 
RNAseq analysis of the BPs prophage in M. chelonae (McProf) showed that only two 
genes are highly expressed. As expected, the immunity repressor (gp33) was highly expressed. 
There was moderate expression from gp58, a gene of unknown function within a 
mycobacteriophage mobile element 1 (MPME1) (Sampson et al., 2009). Left arm genes, 
including gp5 and gp23 – 26 had low-level expression. Gp5 has no predicted function, although 
 
Figure 3.1 Phamerator map of the BPs 
integration cassette. The coordinates of the 
BPs genome are represented by the ruler. 
Genes are shown as colored boxes above 
(transcribed rightwards) or below (transcribed 
leftward) the ruler. RNAseq profiles are shown 
for forward (blue) and reverse (red) DNA 
strands. Note that the sequence reads are 
mapped to the viral BPs genome rather than 
prophage The map was generated using 






HHpred analysis resulted in strong hits to a ribosome modulation factor (Zimmerman et al., 
2018). Due to its location within an operon encoding structural genes, it is also likely functions 
in particle assembly and structure. Gp23 – 26 also do not have predicted functions, but their 
positioning between minor tail proteins and the lysis cassette suggests that they are also lytic 
genes. It is likely that the low number of reads mapping to gp5 and gp23 – 26 are a result of 
































































































































































































































































































































































3.4.2 BPs gp5 does not drive changes in whiB7 expression 
 Since we observed a significant increase in whiB7 expression in M. chelonae (BPs, 
McProf) relative to the wildtype strain carrying McProf only, we decided to explore the impact 
of BPs lysogenic genes expressed in the double lysogen on whiB7 expression in the presence of 
prophage McProf, beginning with gp5.  
 BPs gp5 is located on the left arm of the phage genome within a region that encodes 
structural genes that are typically only expressed during lytic growth. However, there is no 
known function associated with this gene. Analysis of the protein coding sequence by blastP 
indicated relation to a ribosome modulation factor identified in E. coli and T. thermophilus with 
69% coverage. Ribosome modulation factors can promote translation of leaderless transcripts 
(Beck and Moll, 2018). Leaderless transcripts are translated by pre-formed 70S ribosomes that 
bind directly to AUG start codons, protecting the transcripts from degradation (Sawyer et al., 
2018; Beck and Moll, 2018). Nearly one quarter of mycobacterial transcriptomes are leaderless, 
meaning ribosome binding does not occur at a ribosome binding site upstream of the transcript 
start site (Canestrari et al., 2020). Since mycobacteria regularly translate leaderless mRNAs and 
therefore carry pre-formed 70S ribosomes, it is possible that expression of gp5 aids in 
stabilization of leaderless transcripts. This may alter mRNA levels of bacterial genes that could 
leads to an increase in expression of whiB7 and its associated antibiotic resistance genes.  
 To investigate the role of gp5 on whiB7 expression, we constructed an overexpression 
vector, pMOgp5, and isolated RNA from recombinant strains of M. chelonae carrying the 
overexpression and control vectors. The gp5 ORF was cloned into pMO21 subclone vector 




that allows for maintenance of the plasmid in the absence of antibiotic selection (Dedrick et al., 
2016). Recombinant and control strains were generated by introducing pMOgp5 and pMOHsp 
respectively into M. chelonae (McProf).  
To ensure that gp5 was being expressed from our recombinant strains, we used qRT-
PCR to measure levels of gp5 transcript in recombinant strains and compared this to gp5 
expression levels in the double lysogen. M. chelonae carrying pMOgp5 expressed gp5 at a level 
more than 20,000-fold higher than M. chelonae (BPs, McProf) (Figure 3.3a).  Overexpression of 
gp5 however did not affect whiB7 expression in the recombinant strain.  M. chelonae 
overexpressing BPs gp5 demonstrated no significant difference in whiB7 expression compared 
to the empty vector control strain, and approximately 60-fold lower expression relative to M. 

















3.4.3 BPs gp33 does not drive changes in whiB7 expression 
 The immunity repressor, gp33, is the most highly expressed gene in the BPs prophage. 
This is expected since phage repressors inhibit expression of genes associated with lytic 
replication while in a lysogenic state (Dedrick et al., 2013; Petrova et al., 2015). Given that 
repressors possess DNA binding capabilities, we wondered whether gp33 could modulate 
bacterial gene expression as well, resulting in upregulation of whiB7. To investigate this, we 
generated a recombinant strain of M. chelonae (McProf) (pMHIR) that encodes the BPs 
immunity repressor (Table 3.2).  
 
Figure 3.3 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs gp5. 
The average relative expression levels of BPs gp5 in M. chelonae (BPs, McProf) and M. chelonae 
(McProf) (pMOgp5) (A) and whiB7 in M. chelonae (McProf) (pMOHsp), M. chelonae (McProf) 
(pMOgp5), and M. chelonae (BPs, McProf) (B) as measured with SYBR Green qRT-PCR. Cultures 
were grown to an OD600 of 1.0 before harvesting RNA in triplicate. Graphs represent average 
values ± standard error of the mean with n=3 and are representative of two independent trials. 




 We modified the integrative vector, pMH94, by removing the L5 integration cassette 
and replacing it with the BPs integration cassette (Lee et al., 1991). Plasmid pMHIR encodes the 
BPs integrase (gp32), the attP site, the entire immunity repressor (gp33) and the upstream 
region including the native promoter. As a control, we constructed an additional vector, 
pMHIattP, which encodes the integrase and attP site, but lacks the 5’ end of the immunity 
repressor. pMHIR and pMHIattP were electroporated into M. chelonae (McProf). Vector 
integration allowed for plasmid maintenance in the absence of antibiotics.  
Expression of gp33 in recombinant M. chelonae (McProf) carrying pMHIR was confirmed 
by qRT-PCR and did not differ from that of the double lysogen (BPs, McProf) (Figure 3.4a). 
whiB7 expression was then assessed by qRT-PCR (Figure 3.4b). BPs gp33 did not significantly 
alter whiB7, with near identical expression between the pMHIR strain and pMHIattP control 
strain. Additionally, whiB7 expression was approximately 50 times greater in M. chelonae (BPs, 
McProf), suggesting that the BPs repressor alone does not contribute to upregulation of whiB7 





3.4.4 Co-expression of BPs gp5 and gp33 does not drive changes in whiB7 expression 
 Since BPs gp5 and gp33 did not impact whiB7 when expressed individually, we explored 
whether co-expression of these genes have an effect on whiB7 expression. The gp33 transcript 
appears to be leaderless, so we wondered if gp5 enhances production of repressor protein 
(Broussard et al., 2013).  
 The pMOgp5 overexpression vector was transformed into the recombinant strain of M. 
chelonae (McProf) expressing gp33 from pMHIR. RNA was isolated from M. chelonae (McProf) 
(pMHIR, pMOgp5) and gp33 expression was compared to that of M. chelonae (BPs, McProf) and 
M. chelonae (McProf) (pMHIR) by qRT-PCR (Figure 3.5a). Interestingly, gp33 expression was 
slightly higher in the strain carrying both pMHIR and pMOgp5 relative to M. chelonae (BPs, 
Figure 3.4 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs 
gp33. The average relative expression levels of BPs gp33 in M. chelonae (BPs, McProf) and 
M. chelonae (McProf) (pMHIR) (A) and whiB7 in M. chelonae (McProf), M. chelonae 
(McProf) (pMHIattP), M. chelonae (McProf) (pMHIR), and M. chelonae (BPs, McProf) (B) as 
measured with SYBR Green qRT-PCR. Cultures were grown to an OD600 of 1.0 before 
harvesting RNA in triplicate. Graphs represent average values ± standard error of the mean 
with n=3 and are representative of two independent trials. Means with different letters 




McProf) and the strain carrying pMHIR alone. We then determined relative whiB7 expression in 
these strains and found that expression was not significantly upregulated in the co-expression 
strain compared to M. chelonae (BPs, McProf) (Figure 3.5b). whiB7 expression was 
approximately 35-fold higher in the double lysogen. There was not a discernable difference in 
whiB7 expression between M. chelonae (McProf) (pMHIR, pMOgp5) and M. chelonae (McProf) 
(pMHIR). Overexpression of gp5 increased expression of gp33. However, this did not lead to 




Figure 3.5 qRT-PCR analysis of recombinant M. chelonae (McProf) strains co-expressing BPs 
gp5 and gp33. The average relative expression levels of BPs gp33 in M. chelonae (McProf) 
(pMHIR), M. chelonae (McProf) (pMHIR, pMOgp5), and M. chelonae (McProf, BPs) (A) and 
whiB7 in M. chelonae (McProf) (pMHIR, pMOHsp), M. chelonae (McProf) (pMHIR, pMOgp5), 
and M. chelonae (BPs, McProf) (B) as measured with SYBR Green qRT-PCR. Cultures were grown 
to an OD600 of 1.0 before harvesting RNA in triplicate. Graphs represent average values ± 
standard error of the mean with n=3 and are representative of two independent trials. Means 




3.4.5 BPs gp58 does not drive changes in whiB7 expression 
 While the role of BPs gp58, encoded by MPME1, is unknown, its significant expression 
and potential to be a DNA binding protein made it worth investigating as a potential mediator 
of bacterial gene expression. Similar to gp5, we developed a recombinant strain of M. chelonae 
(McProf) expressing the gp58 ORF from the plasmid pMO21 to generate M. chelonae (McProf) 
(pMOgp58). We also generated a strain carrying the plasmid, pMOgp57 – 58, which lacks the 
Hsp60 promoter but encodes the entire MPME1 sequence to include its native promoter (Table 
3.2). To determine if increased whiB7 expression occurs in double lysogens that lack gp58, we 
created a lysogen of M. chelonae (McProf) using cluster G1 phage, CLED96, which is nearly 
identical in sequence to BPs but lacks MPME1.  
RNA was isolated from each strain and gp58 expression was confirmed by qRT-PCR 
(Figure 3.6a). Expression of gp58 from pMOgp58 was over 2,000-fold higher relative to M. 
chelonae (BPs, McProf) and expression of gp58 from pMOgp57 – 58 was comparable to the 
double lysogen. Relative expression of whiB7 was then measured (Figure 3.6b). whiB7 
expression did not significantly differ between the control strain M. chelonae (McProf) 
(pMOHsp) and M. chelonae (McProf) strains expressing gp58 from the Hsp60 promoter 
(pMOgp58) or from the MPME1 promoter (pMOgp57 – 58). Expression of whiB7 was 
approximately 40-fold higher in M. chelonae (BPs, McProf) compared to gp58 expression 
strains. Interestingly, M. chelonae (CLED96, McProf) demonstrated a 10-fold increase in whiB7 
expression relative to the gp58 expression and control strains but was still significantly lower 






 The prevalence of non-tuberculous mycobacterial disease has been steadily increasing 
in recent years. Treatment of these diseases, specifically M. abscessus infections, is difficult to 
manage due to extreme intrinsic drug resistance, posing a major health threat (Johansen et al., 
2020). Further, emergence of extensively antibiotic resistant isolates of M. abscessus has 
rendered successful clearance of disease nearly impossible (Johansen et al., 2020). Extensive 
resistance in some M. abscessus strains can be attributed to mutations in 16S or 23S rRNA, the 
targets for aminoglycosides and macrolides respectively. However, mutations do not account 
for extensive resistance observed in all clinical isolates (Guo et al., 2020). Common among 
 
Figure 3.6 qRT-PCR analysis of recombinant M. chelonae (McProf) strains expressing BPs 
gp58. The average relative expression levels of BPs gp58 in M. chelonae (BPs, McProf) M. 
chelonae (McProf) (pMOgp57 – 58), and M. chelonae (McProf) (pMOgp58) (A) and whiB7 in 
M. chelonae (McProf) (pMOHsp), M. chelonae (McProf) (pMOgp57 – 58), M. chelonae 
(McProf) (pMOgp58), M. chelonae (CLED96, McProf), and M. chelonae (BPs, McProf) (B) as 
measured with SYBR Green qRT-PCR. Cultures were grown to an OD600 of 1.0 before harvesting 
RNA in triplicate. Graphs represent average values ± standard error of the mean with n=3 and 
are representative of two independent trials. Means with different letters are significantly 




extensively resistant M. abscessus strains is upregulation of transcriptional activator, whiB7, 
which regulates many genes associated with antibiotic resistance and stress adaptation (Guo et 
al., 2020; Morris et al., 2005; Burian et al., 2012). While whiB7 expression is known to be 
induced by stress conditions such as sub-lethal drug exposure, phage infection, and the 
intracellular environment of macrophages, the cause of upregulation in extensively resistant M. 
abscessus remains unknown (Cushman et al., 2021; Burian et al., 2012). Better understanding 
mechanisms of drug resistance in pathogenic mycobacteria is essential for developing more 
effective treatments.  
 We recently reported on the novel observation that phage infection impacts whiB7 
expression in mycobacteria. The presence of prophage BPs increases expression of whiB7 in M. 
chelonae, but only in strains carrying the naturally occurring prophage, McProf. This suggests 
that an interaction between BPs and McProf triggers an upregulation of whiB7 (Cushman et al., 
2021). McProf is only able to carry out lysogenic infection in M. chelonae. However, it appears 
that BPs carries out both lytic infection and lysogenic infection in a population of M. chelonae 
(BPs, McProf) cells (Cushman et al., 2021). It is unclear whether lytic or lysogenic BPs gene 
expression alters whiB7 expression in the presence of McProf. Here we describe the role of BPs 
lysogenic gene products on whiB7 expression in strains of M. chelonae carrying the McProf 
prophage. 
 The function of gp5 is unknown, but HHpred analysis showed strong hits to a ribosome 
modulation factor (Zimmerman et al., 2018). Ribosome modulation factors have the potential 




Regardless of its true function, gp5 does not appear to contribute to increased whiB7 
expression (Figure 3.3b).   
The immunity repressor, gp33, is the most highly expressed gene from BPs and as a DNA 
binding protein, was a likely candidate for altering bacterial gene expression. High expression of 
the immunity repressor is expected given its role in preventing expression of lytic genes 
(Petrova et al., 2015). We attempted to overexpress gp33 in M. chelonae (McProf) using a 
pMOHsp backbone, which allows for maintenance of the plasmid through a ParABS system in 
the absence of antibiotic selection (Dedrick et al., 2016). However, the gp33 recombinant 
pMOHsp vector proved to be highly unstable and appeared to be lethal to bacterial cells. As an 
alternative, we engineered the integrative plasmid, pMH94, to express the BPs repressor and 
integration cassette from its native promote in place of the original L5 integration cassette. Our 
analysis suggested that expression of gp33 alone in M. chelonae (McProf) does not significantly 
change whiB7 expression (Figure 3.4b). Since gp33 is expressed as a leaderless transcript 
(Broussard et al., 2013), we wondered if gp5 expression was necessary to facilitate translation 
of gp33 by stabilizing the population of pre-formed 70S ribosomes. We co-expressed gp5 and 
gp33 in M. chelonae (McProf) but found that whiB7 expression was not altered under these 
conditions (Figure 3.5b). However, gp33 expression was nearly doubled in the co-expression 
strain relative to M. chelonae (BPs, McProf) (Figure 3.5a). This suggests that when expressed at 
a high level, gp5 may somehow enhance expression of gp33, potentially as a ribosome 
modulation factor that aids in stabilization of leaderless transcripts by recruiting 70S ribosomes 




increased gp33 transcript detected in M. chelonae (McProf) cells carrying both pMHIR and 
pMOgp5.  
 While gp33 does not appear to impact whiB7 expression in M. chelonae, it is possible 
that it has an alternate role in regulating bacterial gene expression. Gp33 functions as a 
repressor by binding a 12-bp conserved palindromic sequence (5’- CGACATATGTCG - 3’) 
upstream of lytic genes to block the binding of transcriptional machinery and prevent lytic gene 
expression during lysogenic infection (Villanueva et al., 2015). We identified eight related 
sequences within the regulatory region of the M. chelonae genome that could potentially serve 
as gp33 binding sites. Of interest are three binding sites located upstream of a padR-like 
transcription factor, which is the second most downregulated gene in M. chelonae (BPs, 
McProf) (Cushman et al., 2021). The function of this transcription factor in M. chelonae is 
unknown, but padR has been reported to regulate genes involved in stress responses, including 
those involved in antibiotic resistance, often by serving as a repressor in other bacterial species 
(Park et al., 2017; Vatlin et al., 2018). It is possible that gp33 inhibits padR expression and 
subsequently results in de-repression of padR-mediated genes in M. chelonae to alter antibiotic 
resistance. However, the relationship between gp33 and padR in altering genotype and 
antibiotic resistance phenotype in M. chelonae would need to be investigated further. 
 BPs gp58 is moderately expressed and is encoded by mycobacteriophage mobile 
element 1 (MPME1) (Sampson et al., 2009). We generated two plasmid constructs to 
investigate the role of gp58 on whiB7: one overexpression vector and one vector carrying the 
native promoter for gp58. Additionally, we analyzed whiB7 expression in M. chelonae (CLED96, 




nearly identical to BPs aside from a four-nucleotide difference and its lack of MPME1. 
Overexpression of gp58 did result in a statistically significant upregulation of whiB7 relative to 
the control strain at a 2-fold increase but was still nearly 40-fold lower than that observed in M. 
chelonae (BPs, McProf). Interestingly, the presence of the CLED96 prophage in M. chelonae 
(McProf) increased whiB7 expression by about 10-fold but was still significantly lower than the 
relative expression seen in M. chelonae (BPs, McProf) (Figure 3.6b). It is possible that 
background lytic infection in double lysogens, regardless of whether the second prophage is 
BPs or CLED96, could trigger an upregulation of whiB7 in the presence of McProf, but that 
another interaction is necessary to see the ~40-fold increase in whiB7 expression observed in 
M. chelonae (BPs, McProf). This suggests that while gp58 alone does not alter whiB7 
expression, it may cooperatively interact with other factors to upregulate whiB7. This is evident 
by the 30-fold drop in whiB7 expression when MPME1 is absent, but the rest of the prophage 
remains intact, as seen in M. chelonae (CLED96, McProf) compared to the BPs double lysogen. 
We do not know the function of gp58, but it is possible that it possesses recombinase activity 
given that it is the only gene encoded on MPME1. If this is true, it is possible that gp58 has DNA 
binding potential and could interact with other BPs genes to alter bacterial gene expression. 
Given that whiB7 expression is known to fluctuate in a cell density-dependent manner, RNA 
isolations and qRT-PCR analysis should be repeated to confirm the impact of the CLED96 
prophage on whiB7 expression in M. chelonae (McProf).  
 This work has allowed us to conclude that while both prophages, BPs and McProf, must 
be present to induce a drastic upregulation of whiB7, individual BPs genes do not interact with 




interaction between these two phages. Therefore, the impact of McProf viral gene products in 
the presence of BPs needs to be investigated to better understand whiB7 induction and 
increased antibiotic resistance in M. chelonae (BPs, McProf). In addition, the role of BPs lytic 























DETERMINING THE ROLE OF THE MCPROF POLYMORPHIC TOXIN CASSETTE ON WHIB7 
EXPRESSION AND ANTIBIOTIC RESISTANCE IN MYCOBACTERIUM CHELONAE 
4.1 Chapter Summary  
Mycobacterium abscessus is a nontuberculous pathogen associated with lung and 
disseminated infections. It is of growing concern due to its steady increase in incidence over the 
last decade (Griffith, 2019; Johansen et al., 2020) and the emergence of extensively drug 
resistant strains that have hindered effective treatment (Griffith, 2019). The majority of 
pathogenic mycobacteria carry integrated bacteriophage genomes (prophage) that are 
hypothesized to contribute to mycobacterial fitness and virulence (Fan et al., 2015). How 
prophage impact bacterial fitness, particularly when they don’t encode an obvious virulence 
factor, is not understood. 
 M. chelonae is a member of the M. abscessus/M. chelonae complex which carries a 
naturally occurring prophage, McProf, that we hypothesize plays a role in mycobacterial fitness 
and antibiotic resistance of the host.  M. chelonae carrying the prophage McProf were 
significantly more resistant to aminoglycosides relative to strains that lacked McProf (Cushman 
et al. 2021). Aminoglycoside resistance was further enhanced by the addition of a second 
prophage, BPs. RNAseq analysis of this strain, M. chelonae (BPs, McProf), showed drastic 
changes in bacterial gene expression relative to strains carrying only McProf, only BPs or no 
prophage. In the double lysogen strain (BPs, McProf) there was significant upregulation of 
whiB7, a conserved mycobacterial transcriptional activator that regulates genes associated with 




al., 2021). The role of BPs lysogenic gene products was evaluated and did not appear to alter 
whiB7 expression. There are numerous genes expressed from the McProf genome in the double 
lysogen but strong gene candidates for regulating bacterial genes involved in the stress 
response is a McProf-encoded polymorphic toxin system. To investigate the role of the 
polymorphic toxin system on whiB7 regulation and amikacin resistance, we constructed a 
strains of M. chelonae (McProf) that encodes three genes from the McProf putative Esx 
secreted polymorphic toxin (PT) system with and without the prophage BPs. qRT-PCR analysis 
demonstrated a 10-fold upregulation of whiB7 expression in the recombinant strain carrying 
BPs relative to control strains, indicating that the McProf PT cassette plays a role in whiB7 
expression levels when BPs is present. However, whiB7 expression levels were more than four 
times lower than that observed in the double lysogen (BPs, McProf). An increase in AMK 
resistance was not observed in recombinant strains. Taken together, these data suggest high 
whiB7 expression may require additional interactions between BPs and the naturally occurring 
prophage, McProf. Identifying prophage-encoded factors that contribute to drug resistance will 
be important in developing alternative treatment strategies for mycobacterial infections. 
4.2 Introduction  
Mycobacterial disease is the second leading cause of death by an infectious agent 
behind COVID-19 (WHO, 2020). Increasing prevalence of multi-drug resistant (MDR) strains has 
rendered previous treatment options ineffective. M. abscessus is a rapidly emerging 
nontuberculous pathogen that is primarily responsible for pulmonary infections but can also 
cause disseminated disease. It is a major contributor to mortality among cystic fibrosis patients 




treatment option consists of a combination therapy using amikacin and clarithromycin for as 
long as 2 years with harsh side effects (Hurst-Hess et al., 2017). Many strains have become 
extensively resistant, or resistant to all available drugs. In some cases, mutations in drug targets 
have been identified that cause this extensive resistance. However, the cause in many 
extensively resistant strains remains unknown, making treatment essentially impossible (Guo et 
al., 2020).  
M. abscessus carries a broad range of antibiotic resistance genes that encode drug efflux 
pumps and proteins that modify either drug targets or the antibiotics themselves, resulting in 
inactivation (Johansen et al., 2020). Transcriptional activator, whiB7, regulates many of these 
genes associated with antibiotic resistance (Morris et al., 2005; Burian et al., 2012). Common 
among all extensively resistant clinical isolates of M. abscessus is increased expression of whiB7 
compared to wild-type strains which may explain increased drug resistance (Burian et al., 2013; 
Hurst-Hess et al., 2017; Guo et al., 2020). whiB7 is known to be upregulated in the presence of 
environmental stressors, including the intracellular environment of a macrophage and 
subinhibitory drug exposure (Morris et al., 2005; Burian et al., 2012). Extensively resistant 
isolates exhibit this same upregulation without exposure to drug treatment or macrophage. 
What triggers this increased expression of whiB7 in the absence of cell stress is not understood 
The majority of MDR strains identified to date also carry one or more integrated viral 
genomes, or prophage. Cells carrying prophage are called lysogens. Nearly all pathogens carry 
prophage that are known to contribute to fitness and virulence (Brussow et al., 2004; Wang et 
al., 2016). In some models, the role and mechanism of prophage impact is clear. This is the case 




to a toxin encoded by the Stx prophage (Kaper et al., 2004). In other models, the role is of 
prophage clear, but the mechanism is not understood. E. coli K12 carries 9 prophages. Research 
showed that as the number of prophages decreased through a series of curing experiments, so 
did resistance to antibiotics. The strain lacking all prophages was most susceptible to drugs 
(Wang et al., 2010). This work shows that there is a link between prophage and increased 
antibiotic resistance, however what this link is remains to be investigated. The majority of 
mycobacterial pathogens also carry prophage, and they are hypothesized to play a role in 
virulence yet remain largely uninvestigated (Fan et al., 2014; Fan et al., 2015; Bibb and Hatfull, 
2002). Identifying the role of prophage in mediating intrinsic antibiotic resistance will provide 
insight for developing new and more effective therapies for mycobacterial disease. 
M. chelonae is a very close relative of M. abscessus, sharing greater than 80% of protein-
coding sequences. However, M. chelonae is a safer alternative to work with while still 
demonstrating characteristics of pathogenic mycobacteria (Morris et al., 2005; van Ingen et al., 
2009; Jaen-Luchoro et al., 2016). This makes M. chelonae an effective model for studying the 
conserved mycobacterial WhiB7 regulon. We have shown that when M. chelonae, which carries 
a naturally occurring prophage, McProf, is infected with a second prophage, BPs, both whiB7 
expression and antibiotic resistance is significantly increased (Cushman et al., 2021). We 
characterized the BPs and McProf prophages and investigated the role of BPs lysogenic gene 
products on whiB7 expression. We found that whiB7 expression was not significantly altered 
when individual BPs lysogenic genes were expressed in the presence of McProf, indicating that 




The McProf prophage expresses 16 genes, of which the majority have no known 
function (Cushman et al., 2021). There is strong expression from a gene cassette located on the 
rightmost arm of the genome characterized as an ESX-secreted polymorphic toxin (PT) system 
that we predict is secreted by a mycobacterial type 7 secretion system (T7SS). Polymorphic 
toxin (PT) systems include a large multidomain PT protein with an N-terminal domain that 
allows export and/or delivery to other cells and a C-terminus toxin domain that targets cellular 
processes (DNAses, RNAses, NADases, etc) (Ruhe et al., 2020). Downstream of the PT gene is an 
immunity protein that neutralizes the toxin domain and prevents self-intoxication (Ruhe et al., 
2020). Polymorphic toxins are secreted or delivered directly to adjacent cells, potentially 
providing a beneficial interaction in cells carrying the immunity protein such as sharing of 
nutrients and induction of cell signaling pathways (Wood et al., 2020; Garcia et al., 2016; Zhang 
et al., 2018). Alternatively, absence of an associated immunity protein results in cell death. The 
PT system of McProf is similar to PT systems described by Dedrick et al. (2021) in M. abscessus 
prophages and include a small ESAT6-like protein with a WXG-100 motif, a PT protein with a 
WXG-100 motif in the N-terminus followed by an immunity protein. The WXG-100 domains may 
allow formation of heterodimers between the ESAT6-like protein and the PT prior to export 
(Dedrick, 2021). McProf gp98 appears to encode the ESAT6-like protein which we are calling a 
WXG-100 family protein. Gp97 is a predicted Tde-like polymorphic toxin that was first 
characterized in Agrobacterium tumefaciens and likely exhibits DNase activity (Ma et al., 2018). 
Gp97 includes a WXG-100 motif, characteristic of T7SS substrates, and a potential T7SS 
secretion signal (YxxxD/E) in the N and C terminus respectively (Daleke et al., 2012). Gp96 




toxins (Ma et al., 2014). RNAseq analysis showed that these genes were not differentially 
expressed in M. chelonae (BPs, McProf) relative to wildtype (McProf only) (Cushman et al., 
2021).  
Toxin systems are activated by danger signals such as phage infection and drug 
exposure, similar to whiB7, and may play a role in stress adaptation (Kumar et al., 2019; Morris 
et al., 2005; Burian et al., 2012; Cushman et al., 2021). It is therefore possible that an active 
McProf-encoded PT system could trigger a WhiB7 stress response. Other stress adaptation 
systems such as toxin/antitoxin (TA) systems encoded by prophage have been shown to 
increase resistance and persistence in the presence of antibiotics. In E. coli, prophage-encoded 
TA pair RalR/RalA increases resistance to broad-spectrum fosfomycin and the RelE toxin of 
prophage Qin leads to persistence in the presence of ciprofloxacin, ampicillin and tobramycin 
(Christensen et al., 2001; Guo et al., 2014; Neubauer et al., 2009). Additionally, prophage-
encoded TA systems have been shown to mediate biofilm formation, stabilize mobile elements 
such as plasmids and prophages, and confer abortive infection (Wang et al., 2011; Yao et al., 
2018; Fraikin et al., 2020; Wozniak et al., 2009; Dedrick et al., 2017). Toxin systems are 
abundant in pathogenic mycobacteria relative to nonpathogens and are highly expressed in 
especially virulent strains of M. tuberculosis (Kumar et al., 2019; Slayden et al., 2018). Further, 
diverse prophage-encoded PT systems have been identified in 25 M. abscessus prophages with 
close relation to McProf, as well as an additional 50 across 14 other Mab clusters, although 
their functions are largely unexplored (Molloy, Unpublished; Dedrick et al., 2021). The role of 




In this study we constructed recombinant strains of M. chelonae (∆McProf) with and 
without the prophage BPs to express the McProf PT cassette (gp96 – 98).  We investigated the 
role of the PT cassette on BPs prophage stability and measured whiB7 expression and amikacin 
resistance in recombinant and control strains in the presence and absence of the BPs prophage.  
4.3 Materials and Methods  
4.3.1 Bacterial and viral strains  
Mycobacterium chelonae (ATCC®35752, American Type Culture Collection, Manassas, VA) 
was grown in liquid Middlebrook 7H9 broth (BD, Sparks, MD) supplemented with 10% oleic 
acid, albumin, dextrose (OAD) and 0.05% Tween 80 at 30˚C with shaking at 230 RPM. The 
wildtype strain of M. chelonae carries a naturally occurring prophage, McProf, and will be 
referred to as M. chelonae (McProf). M. smegmatis MC2155 (ATCC®700084, American Type 
Culture Collection) was cultivated in the same media in the absence of Tween 80 and grown at 
37˚C with shaking. Kanamycin (KAN) was used as a selective measure for recombinant strains, 
at a concentration of 250 μg mL-1 in liquid and solid media. Competent E. coli DH5  cells were 
prepared by New England Biolabs, (Ipswich, MA) and grown in Luria broth base, Miller (BD) 
supplemented with 50 μg mL-1 of KAN at 37˚C with shaking at 230 RPM for propagation of 
plasmids. Bacterial strains used in this work are listed in Table 4.1. Plasmids used in this study 
are listed in Table 4.2.   
Mycobacteriophage BPs was obtained from the Hatfull Laboratory (Sampson et al., 2009) 
and cultivated by plaque assay using M. chelonae (McProf) or M. smegmatis MC2155. Serially 
diluted phage samples were incubated for 15 min at room temperature in 0.5-ml aliquots of 




agar plates. High titer phage lysate stocks were generated by flooding bacterial lawns with 
nearly confluent lysis with phage buffer (10 mM Tris/HCl pH 7.5, 10 mM MgSO4, 1 mM CaCl2, 
68.5 mM NaCl). Viral strains used in this study are listed in Table 4.1. 
 
4.3.2 RNA isolation  
Total RNA was extracted from four replicates of 4-mL samples of M. chelonae strains at 












Germantown, MD) and centrifuged at 5,000 x g for 10 min. Cell pellets were resuspended in 
100 L of Tris-ethylenediaminetetraacetic acid (TE) with 20 mg mL-1 of lysozyme and incubated 
at room temperature for 40 min. Cells were treated with 700 L of RLT buffer (Qiagen) and 
transferred to 2-mL Lysing Matrix B tubes (MP Biomedicals, Irvine, CA). Samples were 
homogenized for 8 min at 50 Hz in a TissueLyser LT (Qiagen). RNA was isolated from cell lysates 
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. DNase 
(Qiagen) treatment was performed on the columns prior to elution in 50 L of hot nuclease-
free water. A second DNase treatment was performed using the Turbo DNA-Free Kit (Thermo 
Scientific, Waltham, MA) according to the manufacturer’s recommendations. RNA 
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Montchanin, DE). RNA quality was assessed through gel electrophoresis using the 
RNA FlashGel System (Lonza, Rockland, ME) according to the manufacturer’s instructions.  
4.3.3 Construction of recombinant strains  
Bacterial expression vector, pMH94 (Lee et al., 1991) is integration-dependent and 
includes an L5 integration cassette and kanamycin resistance gene. The vector was linearized 
with EcoRI per the manufacturer’s recommendations (NEB). The McProf polymorphic toxin 
cassette (gp96 – 98), including its native promoter (63,600 − 68,223 bp) was PCR amplified with 
primers that include 30-bp extensions that correspond to the ends of EcoRI-digested pMH94. 
The 3,628-bp insert was ligated into the vector using the Gibson Assembly Cloning Kit (NEB) and 
transformed into competent E. coli DH5 according to the manufacturer’s instructions. Plasmid 
was propagated in E. coli and successful recombinant plasmid was confirmed by diagnostic PCR 




Recombinant plasmids were electroporated into competent M. chelonae (∆McProf) 
according to de Moura et al. (2014). Briefly, electrocompetent M. chelonae cells were prepared 
by washing with ice-cold 10% glycerol four times. Plasmid DNA in 500 ng quantities were 
electroporated with 100 µL of electrocompetent M. chelonae in 0.2-cm gap cuvettes. A sample 
of electrocompetent cells lacking plasmid DNA served as a negative control. Electroporation 
was carried out in a single pulse at 2.5 kV, 25 mF, 1,000 Ω. Cells were suspended in 900 µL of 
room-temperature 7H9-OAD and incubated at 30˚C with shaking for 4 h prior to plating on 
7H10-OAD agar plates supplemented with 250 µg mL-1 of KAN. Transformants were PCR 
screened for the presence of the plasmid (Table 4.3). Because our work involved analysis of 
gene expression, specifically whiB7, plasmids were not maintained with antibiotic selection 
following generation of recombinant strains. pMH94 was maintained by integration into the L5 
attachment site. Successful expression of target genes in recombinant strains was confirmed by 












4.3.4 Isolation of lysogenic strains 
To generate BPs lysogen strains, M. chelonae (∆McProf) recombinant strains were 
serially diluted and plated in 4.5 mL of 7H9 top agar onto 7H10-OAD agar plates. One set of 
plates was treated with 109 plaque forming units (PFUs) of BPs, while the second set was 
untreated. Plates were then incubated for 6 d at 30˚C. Resulting colonies were grown in 7H9 








calculated by dividing the number of colonies on virus-treated plates by the number of colonies 
on non-treated plates and multiplying by 100 to yield a percentage. Primers were designed to 
PCR amplify BPs attachment sites, attL and attR, to confirm prophage integration for continued 
cultivation of lysogen strains (Table 4.3).  
4.3.5 Phage particle release test 
 Cultures of recombinant M. chelonae (BPs) were grown to an optical density of 1.0. A 1-
mL sample of each strain was harvested. Cells were pelleted by centrifuging at 16,000 x g for 1 
min. Resulting supernatant was passed through a 2-m filter (VWR International, Radnor, PA) 
to remove residual bacterial cells and serially diluted 10-fold. Lawns of M. smegmatis were 
created by mixing 0.5-mL of late log phase bacteria with 4.5 mL of 7H9 top agar and plating 
onto 7H10 solid agar. Supernatant dilutions were applied in 5-L volumes onto bacterial lawns 
and incubated overnight at 37˚C.  
4.3.6 cDNA synthesis and qRT-PCR 
cDNA was synthesized in 20-L reactions containing 500 ng of total RNA using the 
qScript cDNA Supermix (Quantabio, Beverly, MA) according to the manufacturer’s 
recommendations. Reactions were run under the following thermal cycle: 5 min at 25˚C, 20 min 
at 42˚C, and 5 min at 85˚C for inactivation. Working stocks of cDNA were prepared by diluting 
samples 1:6 in 10 mM Tris.  
 Primers for quantitative real-time PCR (qRT-PCR) assays were designed to amplify a 100-
bp region with the gene of interest using Primer3 (Table 4.4). qRT-PCR assays were carried out 
in triplicate reactions in 25-L volumes containing 200 nM of each primer, 1 L of cDNA (diluted 




instructions. Positive and no-template controls were included in each assay. Reactions were run 
using the Bio-Rad CFX96 Real-Time system (Bio-Rad Laboratories, Hercules, CA). Reactions were 
initially incubated for 3 min at 95˚C, followed by 40 cycles of 10 s at 95˚C and 30 s at 60˚C, and 
lastly a melt curve to confirm a single amplicon per target gene. Change in RNA abundance was 
normalized to M. chelonae 16S rRNA, and relative expression determined using the 2-∆∆CT 
method (Livak et al., 2001).  
 
4.3.7 Minimum inhibitory concentration assays  
Minimum inhibitory concentration (MIC) assays were performed according to Burian and 
coworkers (Burian et al., 2012) and Ramon-Garcia and coworkers (Ramon-Garcia et al., 2013). 
Cultures were grown in 7H9-OAD supplemented with 0.05% Tween80 at 30˚C with shaking and 
sub-cultured such that overnight incubation resulted in an OD600 of 0.1 - 0.3. Cultures were 
diluted to an OD of 0.005 without Tween and incubated for a 1 h and applied in 50-L volumes 








varied by 2-fold dilutions (528 – 4 g mL-1). Each strain was applied in replicates of six at each 
drug concentration and no-antibiotic controls were performed in replicates of 16. Additionally, 
no-bacteria controls were included to serve as an absorbance blank. Inoculated plates were 
sealed with porous adhesive culture plate films (VWR International), wrapped with parafilm and 
incubated at 30°C for 2 d. A 5% solution of Tween80 and AlamarBlue (Bio-Rad) was added to 
each well in 25- and 2-L volumes respectively, incubated at 30˚C for 1 d, and OD measured at 
570- and 600 nm. Percent viability of cells was calculated as the percent difference in reduction 
between antibiotic-treated cells and untreated cells according to the manufacturer’s 
instructions. Each assay was replicated in three independent experiments. 
4.4 Results 
4.4.1 Generation of recombinant M. chelonae strains 
 Bacterial expression vector, pMH94, is integration-dependent and includes an L5 
integration cassette and kanamycin resistance gene for plasmid maintenance (Lee et al., 1991). 
Because our work involved analysis of gene expression and antibiotic resistance, it was 
important to utilize a vector that would not require antibiotic selection.  The region of the 
McProf genome (coordinates 63,600 − 68,223 bp) that includes the polymorphic toxin cassette 
(gp96 − 98) and its native promoter was PCR amplified and inserted into linearized pMH94 to 
create pMHESX (Table 4.2). pMHESX and control vector, pMH94, were electroporated into M. 
chelonae (∆McProf). BPs lysogens were created from strains M. chelonae (pMHESX) and M. 
chelonae (pMH94) in order to determine if the McProf PT system stabilizes the BPs prophage 




4.4.2 Expression of the McProf polymorphic toxin cassette stabilizes BPs single lysogens of M. 
chelonae 
 Phage-encoded toxin systems are reported to aid in stabilization of replicative elements, 
including plasmids and prophages (Yao et al., 2018). We wondered if the McProf PT cassette 
stabilizes the BPs prophage given the increased efficiency of lysogeny and reduced particle 
release observed in M. chelonae (BPs, McProf) relative to the BPs single lysogen (Cushman et 
al., 2021). BPs lysogens of M. chelonae (pMHESX) and the control strain, M. chelonae (pMH94), 
were grown to an optical density of 1.0 and phage particle release was measured in culture 
supernatant (Figure 4.1). There was a difference of two orders of magnitude between the two 
strains, with phage particles detected at concentrations of 2 x 107 PFU mL-1 and 2 x 105 for M. 
chelonae (BPs) (pMH94) and M. chelonae (BPs) (pMHESX) respectively. Although we did not 
determine if McProf PT system proteins are produced from the pMHESX plasmid, the 
stabilization of the BPs prophage in the presence of pMHESX suggests that McProf PT system 






4.4.3 The McProf polymorphic toxin cassette triggers upregulation of whiB7 in the presence 
of phage BPs  
 To determine whether expression of the McProf-encoded PT cassette alters whiB7 
expression in the presence of BPs, we measured relative whiB7 expression in recombinant 
strains, and in M. chelonae (McProf) and M. chelonae (BPs, McProf) by qRT-PCR (Figure 4.2). 
Expression of whiB7 was significantly elevated (approximately 10-fold) in M. chelonae (BPs) 
(pMHESX) relative to M. chelonae (∆McProf) (pMH94). However, expression of whiB7 in M. 
chelonae (BPs) (pMHESX) was not as high as whiB7 expression levels in the double lysogen 
strain, which demonstrated a 45-fold increase relative to M. chelonae (∆McProf) (pMH94). As 
expected, expression of the PT cassette in the absence of BPs (M. chelonae (∆McProf) 
(pMHESX)) did not alter whiB7 expression. This suggests that while the McProf PT cassette 
 
Figure 4.1 Phage particle release in recombinant M. chelonae (BPs). Supernatant of 
recombinant M. chelonae (BPs) (pMH94) (A) and M. chelonae (BPs) (pMHESX) (B) were serially 





elevates whiB7 expression in the presence of BPs, it is not the only factor causing the drastic 
increase in whiB7 expression observed in M. chelonae (BPs, McProf). 
 
4.4.4 The McProf polymorphic toxin cassette is downregulated in M. chelonae (BPs, McProf)  
 We confirmed that each of the PT cassette genes were expressed from pMHESX 
recombinant M. chelonae strains by qRT-PCR and compared expression to that observed in M. 
chelonae (McProf) and M. chelonae (BPs, McProf) (Figure 4.3). The expression profile of the 
recombinant strains differed from that of the double lysogen (BPs, McProf). The WXG-100 
 
Figure 4.2 qRT-PCR analysis of whiB7 in recombinant strains of M. chelonae expressing the 
McProf polymorphic toxin cassette. The average relative expression levels of whiB7 was 
measured in recombinant strains of M. chelonae (∆McProf) and M. chelonae (BPs) carrying 
pMHESX or empty vector (pMH94) and compared to whiB7 expression in M. chelonae (McProf) 
and M. chelonae (BPs, McProf) by SYBR Green by qRT-PCR. Cultures were grown to an OD600 of 
1.0 before harvesting RNA in triplicate. Graphs represent average values ± standard error of 
the mean with n=3 and are representative of two independent trials. Means with different 




family protein and Tdi-like immunity protein were expressed at similar levels in both M. 
chelonae (∆McProf) (pMHESX) and M. chelonae (∆McProf) (BPs) (pMHESX) relative to M. 
chelonae (McProf) (Figure 4.3a and Figure 4.3c). However, expression of these genes in the 
double lysogen was significantly lower. The expression levels of gp97, the Tde-like PT, was 
higher in both recombinant strains, M. chelonae (∆McProf) (pMHESX) and M. chelonae (BPs) 
(pMHESX) by approximately 6.5-fold and 5-fold relative to M. chelonae (McProf) whereas 
expression levels in the double lysogen were the lowest (Figure 4.3b). This suggests that the 
presence of an intact McProf prophage affects expression of gp97. Interestingly, all three genes 
in the PT cassette were downregulated in M. chelonae (BPs, McProf). The presence of the BPs 
prophage also appears to affect expression of genes in the PT system. The different expression 
profiles between the single McProf and double lysogen (BPs, McProf) strains is in contrast from 
















Figure 4.3 2-∆∆Ct qRT-PCR analysis of 
polymorphic toxin cassette genes in 
recombinant M. chelonae strains. The 
average expression of the WXG-100-like 
protein (A), the Tde-like polymorphic 
toxin (B), and the Tdi-like immunity 
protein (C) was measured in recombinant 
strains of M. chelonae (∆McProf) and M. 
chelonae (BPs) carrying pMHESX, as well 
as in M. chelonae (McProf) and M. 
chelonae (BPs, McProf), by SYBR Green 
qRT-PCR. Cultures were grown to an 
OD600 of 1.0 before harvesting RNA in 
triplicate. Graphs represent average 
values ± standard error of the mean with 
n=3 and are representative of two 
independent trials. Means with different 






To compare the ratio of PT to immunity protein, we plotted the average ∆Ct for each 
gene by strain (Figure 4.5). The Tdi-like immunity protein is the most highly expressed gene in 
the PT cassette in McProf-carrying strains, and PT expression is lower in McProf-carrying strains 
compared to recombinant strains. In contrast, PT expression is higher in the recombinant 
strains and immunity protein expression in nearly equivalent to that of the toxin, indicating that 
the ratio of immunity protein to PT transcripts differ in the absence of an intact McProf 
prophage (Figures 4.4 and 4.5). M. chelonae (BPs, McProf) has lower expression across the 
entire cassette compared to other strains and the WXG-100 protein has the lowest expression 
of the three PT cassette genes across all strains, as indicated by elevated ∆Ct values.  
 Figure 4.4 McProf polymorphic toxin 
cassette gene expression profile. The 
coordinates of the McProf genome are 
represented by the ruler. Genes are shown 
as boxes above (transcribed rightwards) or 
below (transcribed leftward) the ruler. 
RNAseq profiles are shown reverse (red) 
DNA strands. The number of reads mapped 
are shown on the y-axis. The map was 




















































































































































































































4.4.5 Expression of the McProf polymorphic toxin cassette does not alter amikacin resistance  
 Previous work demonstrated that the presence of both BPs and McProf prophages 
significantly increased the resistance of M. chelonae to aminoglycoside, amikacin, relative to 
strains carrying one or no prophage (Cushman et al., 2021). We investigated whether 
expression of the McProf PT genes in the recombinant strains in the presence and absence of 
BPs increased AMK resistance through MIC assays (Figure 4.6). The AMK MIC was measured in 
recombinant M. chelonae (∆McProf) and M. chelonae (BPs) expressing the PT cassette 
(pMHESX) compared to respective strains carrying empty vector (pMH94). There was no 
 
Figure 4.5 ∆Ct qRT-PCR analysis of McProf polymorphic toxin cassette genes in 
recombinant M. chelonae strains. The average expression of the WXG-100-like protein 
(blue), the Tde-like polymorphic toxin (purple), and the Tdi-like immunity protein (green) was 
measured in recombinant strains of M. chelonae (∆McProf) and M. chelonae (BPs) carrying 
pMHESX, as well as in M. chelonae (McProf) and M. chelonae (BPs, McProf), by SYBR Green 
qRT-PCR. Cultures were grown to an OD600 of 1.0 before harvesting RNA in triplicate. Graphs 
represent average values ± standard error of the mean with n=3 and are representative of 
two independent trials. Significantly different means by gene across all strains are 





significant difference in AMK resistance between the PT recombinant strains relative to control 
strains carrying empty vector. The presence of the BPs prophage also did not affect AMK 
resistance. The MIC for all four recombinant strains with and without the BPs prophage was 16 
g mL-1. All strains showed enhanced resistance upon ACI treatment at an MIC of 32 g mL-1. 
However, ACI treatment did not have a greater effect on M. chelonae (BPs) (pMHESX) 
compared to M. chelonae (∆McProf) (pMHESX), nor did strains carrying the control vector 
demonstrate lower resistance upon ACI treatment relative to pMHESX-carrying strains.  







4.4 Discussion  
The incidence of non-tuberculous mycobacterial disease has been on the rise and poses a 
major public health threat. Effective treatment of these diseases, especially M. abscessus 
infections, has proven to be difficult as a result of high levels of intrinsic drug resistance 
(Johansen et al., 2020). Further, emergence of extensively antibiotic resistant isolates of M. 
abscessus has rendered successful clearance of infections nearly impossible (Johansen et al., 
2020). Extensive resistance in some M. abscessus strains can be attributed to mutations in 16S 
or 23S rRNA, the targets for aminoglycosides and macrolides respectively. However, mutations 
 
Figure 4.6 Percent viability of recombinant M. chelonae strains upon AMK treatment in the 
presence and absence of ACI. Percent viability of M. chelonae (∆McProf) (McMP), and M. 
chelonae (BPs) (Mc (BPs) carrying pMHESX (ESX) or empty vector (94)) in the presence of 
varying concentrations of amikacin. To determine if the presence of the McProf PT cassette 
interacts with sub-inhibitory concentrations of antibiotics, each strain was treated or not 
treated with 75 μM acivicin (ACI). Graphs represent average values  SE of the mean with n=3. 
The optical density of was measured at 570- and 600 nm after the addition of 2 μL of 
AlamarBlue and the percent difference in reduction between antibiotic-treated cells and 




do not account for extensive resistance observed in all clinical isolates (Guo et al., 2020). 
Common among extensively resistant M. abscessus strains is upregulation of transcriptional 
activator, whiB7, which positively regulates many genes associated with antibiotic resistance 
and stress adaptation (Guo et al., 2020). While whiB7 expression is known to be induced by 
stress conditions such as sub-lethal drug exposure, phage infection, and the intracellular 
environment of macrophages, the cause of upregulation in extensively resistant M. abscessus is 
not completely understood (Cushman et al., 2021 and Burian et al., 2012). Better understanding 
mechanisms of intrinsic drug resistance in pathogenic mycobacteria is essential for developing 
more effective treatments.  
 We recently demonstrated for the first time that phage infection impacts whiB7 
expression in mycobacteria. The presence of prophage BPs increases expression of whiB7 in M. 
chelonae, but only in strains carrying the naturally occurring prophage, McProf. This suggests 
that an interaction between BPs and McProf triggers an upregulation of whiB7 (Cushman et al., 
2021). Expression of individual BPs lysogenic gene products did not significantly alter whiB7 
expression, suggesting that lytic infection by BPs and/or McProf gene products play a more 
important role in altering whiB7 expression and antibiotic resistance (Molloy, Unpublished). 
Here we explore the role of the McProf-encoded polymorphic toxin (PT) cassette on prophage 
stability, whiB7 expression and amikacin resistance. We show that expression of the PT cassette 
alone in the presence of the BPs prophage does significantly increase whiB7 expression but not 
to the same degree of high expression levels observed in M. chelonae (BPs, McProf).  
 The genes in the McProf PT system play a role in stabilizing the BPs prophage in 




McProf prophage with culture supernatant titers approaching 1010 PFU mL-1.  In contrast, 
culture supernatant titers of BPs lysogens of M. chelonae (McProf) or the PT recombinant strain 
are 2 – 4 orders of magnitude lower (Figure 4.1) (Cushman et al., 2021). Active polymorphic 
toxin systems are known to aid in the stabilization of replication elements, including prophage 
and plasmids (Yao et al., 2018; Fraikin et al., 2020; Wozniak et al., 2009). We did not measure 
protein production from gp96 – 98 in the recombinant strains. However, the drastic difference 
in BPs titer in culture supernatants in the recombinant strains relative to controls suggests that 
active gene products are likely being made at a high enough level to stabilize the BPs prophage, 
possibly by killing cells in which BPs induction occurs. 
 The McProf PT system contributes to the whiB7 response, but not to the same degree as 
strains carrying an intact McProf prophage. Toxin/antitoxin and polymorphic toxin systems are 
activated by stressors such as phage infection and antibiotic exposure, and are abundant in 
pathogenic mycobacteria (Kumar et al., 2019; Slayden et al., 2018; Wang et al., 2011). These 
systems may also contribute to stress adaptation responses (Slayden et al., 2018). Our analysis 
suggested that while expression of the PT cassette in M. chelonae (BPs) (pMHESX) does 
increase whiB7 expression by approximately 10-fold, this system alone does not explain the 
>40-fold increase observed in the double lysogen (BPs, McProf) (Figure 4.2). This likely explains 
why there is not a difference in AMK resistance observed in pMHESX strains (Figure 4.5), 
although MIC data is preliminary and should be repeated. It is possible that an additional 
McProf-encoded factor(s), independently or through interactions with the PT cassette, are 
necessary for high whiB7 expression in the presence of BPs. Therefore, the role of the other 13 




The PT cassette was actively expressed in recombinant strains; however, the expression 
profiles contrasted those observed from RNAseq. While it remains true that the immunity 
protein is the most highly expressed gene in the cassette, we found that expression of all three 
PT cassette genes is significantly lower in M. chelonae (BPs, McProf) compared to both wildtype 
M. chelonae and the recombinant strains (Figure 4.3). It is possible that differential expression 
was not detected in RNAseq analysis as a result of low read coverage. While the McProf PT 
cassette appears to be transcribed on the same operon, the stark difference in reads mapped 
to the WXG-100 protein and the N-terminus of the toxin compared to the immunity proteins 
suggests that there may be a hidden promoter within the C-terminus of the PT ORF that would 
explain the heightened expression of the immunity protein in McProf-carrying strains (Figure 
4.4). Together, this suggests that the McProf PT cassette is downregulated in the double 
lysogen (BPs, McProf) but not when BPs alone is present, indicating that another McProf-
encoded component plays a role in regulating the polymorphic toxin system.  
 The difference in whiB7 expression between the recombinant BPs lysogen and the 
double lysogen may be due to differences in the gene expression profile of the PT cassette 
between strains. The Tdi-like immunity protein (McProf gp96) is more highly expressed than its 
associated Tde-like toxin (McProf gp97) in McProf-carrying strains, whereas in the recombinant 
strains, expression of the immunity protein and PT were nearly equal (Figure 4.5). It makes 
sense for the ratio of immunity protein to toxin to be high in order to protect cells from PT 
activity and similar expression profiles have been observed in prophage-encoded PT systems 
identified in clinical M. abscessus strains (Dedrick et al., 2021; Harms et al., 2018). If PT 




PT would likely affect residual toxin activity and potentially whiB7 expression. However, though 
the PT cassette expression profiles between the recombinant strains are highly similar, this 
would not explain the 10-fold difference in whiB7 expression in the presence and absence of 
BPs. This suggests that the presence of the BPs phage likely affects regulation of the toxin 
system at the post-transcriptional level. Because an intact McProf prophage is also important 
for high whiB7 expression, it too may be important to PT protein activity and potentially results 
in increased whiB7 expression. In Enterococcus, T7SS PT systems are known to be upregulated 
by phage infection (Chaterjee et al., 2021). The presence of an intact McProf genome may 
result in phage gene expression that activates the PT system in a way that affects whiB7 
expression which cannot be observed in our recombinant strains.  
 We have shown that the McProf PT system does contribute to the whiB7 response in 
the presence of the BPs prophage; however, the PT cassette alone does not explain the 45-fold 
increase in whiB7 expression observed in M. chelonae (BPs, McProf). The impact of the other 
genes expressed from the McProf prophage should be investigated in the presence of both the 
PT cassette and BPs to explore whether a combination of McProf-encoded gene products is 












CHAPTER 5  
CONCLUDING REMARKS AND FUTURE DIRECTIONS  
Pathogenic mycobacteria pose a major public health threat and are the second leading 
cause of death by an infectious agent behind COVID-19 (WHO, 2020). Nontuberculous 
mycobacterial pathogens are gaining prevalence, surpassing the incidence of tuberculosis in 
most developed countries (Johansen et al., 2020). Mycobacterium abscessus is the most 
intrinsically antibiotic-resistant species known. It is the causative agent of lung infections that 
disproportionately affect immunocompromised individuals, such as cystic fibrosis patients. 
These characteristics make M. abscessus infections difficult to treat, with a success rate of only 
45% (Griffith, 2019; Johansen et al., 2020). Further, emergence of extensively antibiotic 
resistant isolates of M. abscessus has rendered successful clearance of disease nearly 
impossible (Johansen et al., 2020). While some extensively resistant isolates are caused by 
mutations in drug targets, others appear to be a result of increased intrinsic drug resistance 
with no known cause (Guo et al., 2020). Common among extensively resistant M. abscessus 
strains is upregulation of conserved mycobacterial transcriptional activator, whiB7, which 
regulates many genes associated with antibiotic resistance and stress adaptation (Guo et al., 
2020; Morris et al., 2005; Burian et al., 2012). The majority of extensively resistant clinical M. 
abscessus strains identified thus far carry one or more prophage (Dedrick et al., 2021; Molloy, 
Unpublished). Prophage are known to contribute to fitness and virulence in many pathogens, 
but their role in mycobacteria has not been established (Fan et al., 2014). Characterizing the 




mycobacteria will be important for identifying new targets for novel drug development (Nessar 
et al., 2012; Dheda et al., 2018).  
This thesis has contributed to understanding the role of prophage on whiB7 expression 
and intrinsic drug resistance in pathogenic mycobacteria. The McProf prophage is found 
naturally in the pathogen M. chelonae where it plays a major role in regulating intrinsic drug 
resistance via upregulating whiB7.  My work suggests it does through the polymorphic toxin 
system encoded within McProf.  McProf belongs to a novel cluster, MabR (Molloy, 
Unpublished). At least 25 clinical isolates of M. abscessus have been identified carrying McProf-
like or MabR prophage sequences (Molloy, Unpublished). Therefore, this work is significant to 
the study of drug resistance in M. abscessus because the polymorphic toxin system encoded by 
McProf is also common in strains of M. abscessus whiB7 pathway that is conserved in all 
mycobacteria. 
We expanded our understanding of this regulatory system by showing that the addition 
of a second prophage, BPs, to M. chelonae (McProf) triggers a >40-fold increase in whiB7 
expression and results in enhanced aminoglycoside resistance. In fact, whole genome RNAseq 
analysis showed differential expression of 8.5% of M. chelonae genes in the presence of BPs. 
We developed a four-strain model including single, double, and non-lysogens of M. chelonae 
and found that both prophages must be present to observe a drastic increase in whiB7 
expression and antibiotic resistance. Sub-lethal levels of Acivicin (ACI), are known to induce 
increased expression of whiB7.  We showed that it not only significantly increased amikacin 
(AMK) resistance in all four strains but had the most pronounced effect on strains carrying 




strain. This allowed us to conclude that an interaction between McProf and BPs induces whiB7 
expression and that exposure to sub-lethal drugs further enhances this effect. Notably, this is 
the first report of phage infection serving as a trigger for the WhiB7 response. However, we saw 
that when exposed to sub-lethal AMK, whiB7 expression was only substantially increased in M. 
chelonae strains lacking McProf. We noted that ACI is a smaller molecule compared to AMK and 
wondered if McProf somehow alters cell wall permeability. This could explain increased AMK 
resistance in McProf-carrying strains, and why sub-lethal AMK doesn’t appear to significantly 
impact whiB7 expression in M. chelonae (McProf) and M. chelonae (BPs, McProf). It would be 
interesting to assess differences in cell wall permeability between all four M. chelonae strains 
by measuring dye uptake using fluorescent microscopy. Ethidium bromide has been 
successfully used to measure rate of uptake and efflux in mycobacteria, as it strongly fluoresces 
when concentrated in the cytoplasm of Gram-positive bacteria (Rodrigues et al., 2011). 
Therefore, these methods could be optimized to measure ethidium bromide uptake in M. 
chelonae, and potentially uncover another layer of intrinsic resistance in mycobacterial 
pathogens.  
Given the dramatic increase in whiB7 expression and aminoglycoside resistance 
observed in M. chelonae (BPs, McProf), but not in single or non-lysogens of M. chelonae, we 
investigated the impact of BPs lysogenic gene products on whiB7 expression in the presence of 
McProf. We identified three genes expressed by the BPs prophage and generated recombinant 
strains of M. chelonae (McProf) to individually express these genes. qRT-PCR analysis 
demonstrated that BPs lysogenic gene products do not significantly alter whiB7 expression. In a 




switch from lysogenic to lytic replication (Casjens, 2003). Therefore, the impact of BPs lytic 
infection on whiB7 expression also needs to be investigated. This can be achieved by infecting 
M. chelonae (McProf) with a BPs mutant that lacks the immunity repressor so that it is only 
capable of lytic growth. We have generated such a strain using BRED technology (Marinelli et 
al., 2008). RNA can be harvested throughout the infection cycle and temporal whiB7 expression 
measured by qRT-PCR. Because the presence of McProf is necessary for whiB7 induction upon 
BPs infection, as seen in M. chelonae (BPs, McProf), it is likely that BPs infection does not 
directly alter whiB7 expression, but rather activates McProf gene products that results in stress 
signaling that triggers a WhiB7 response. Therefore, the relative expression of McProf genes 
should be monitored during lytic infection as well. Alternately, generation of a “super” double 
lysogen by overexpressing the BPs immunity repressor in M. chelonae (BPs, McProf) would 
serve two purposes. First, it could confirm that BPs lysogenic gene products truly do not 
influence whiB7 expression. Second, overexpression of the immunity repressor would greatly 
minimize or entirely prevent induction events. Overexpression of the BPs immunity repressor 
was previously attempted using a constitutive Hsp60 promoter and appeared to be lethal to the 
cell. To circumvent this, an inducible promoter could be used to control repressor expression 
levels. If whiB7 expression is not upregulated in a super double lysogen, then it would be 
plausible to further investigate BPs induction events as a contributor to whiB7 induction in the 
presence of McProf.  
Since BPs lysogenic gene products did not contribute to whiB7 upregulation, we looked 
into the role of McProf gene products, specifically the polymorphic toxin (PT) cassette. While 




chelonae (BPs), it did not fully account for the 45-fold increase observed in M. chelonae (BPs, 
McProf). This suggests that other McProf-encoded factors may contribute to the induction of 
whiB7 or affect the expression and/or activation of the McProf PT system such that higher 
whib7 expression occurs and therefore should be investigated. McProf expresses 13 genes in 
addition to the PT cassette. Each of these genes should be cloned into M. chelonae (BPs) and 
the impact on whiB7 expression and aminoglycoside resistance evaluated. Of specific interest is 
gp84. It does not have a predicted function; however, it is the most highly expressed McProf 
gene. It is therefore possible that this gene product is somehow beneficial to McProf and/or its 
bacterial host.  
Another aspect to consider is a potential interaction between the McProf PT system and 
an M. chelonae-encoded flotillin protein. The most highly upregulated gene in M. chelonae 
(BPs, McProf) relative to the wildtype strain encodes a predicted flotillin protein with a 99-fold 
increase in expression (Cushman et al., 2021). As it is not a member of the WhiB7 regulon, it 
was not previously investigated, but orthologs have been identified in M. tuberculosis and M. 
abscessus. The function of this gene in M. chelonae in unknown; however, in multidrug 
resistant Staphylococcus aureus, it serves as a chaperone and contributes to virulence by 
interacting with functional membrane microdomains and type 7 secretion system (T7SS) 
components (Mielich-Suss et al., 2017). Further, phage infection in Enterococcus faecalis results 
in increased expression of T7SS components and its substrates (Chaterjee et al., 2021). Taken 
together, it is possible that the M. chelonae flotillin protein could be facilitating interactions 
between T7SS substrates, such as the McProf-encoded polymorphic toxin, and the bacterial 




response. The impact of the McProf PT cassette on flotillin expression should be measured by 
qRT-PCR to determine whether there is a link between the two systems. Additionally, a flotillin 
knockout strain should be created from M. chelonae (BPs, McProf) to assess whether the 
flotillin protein is involved in triggering an upregulation of whiB7.  
In summary, this work has identified phage infection as a novel trigger of the WhiB7 
stress response and increased drug resistance and has begun to uncover potential mechanisms 
responsible for this response. Continuing to characterize these phage-host interactions is 
important to better understanding the virulence of mycobacterial pathogens. Elucidating the 
mechanisms of whiB7 upregulation and increased antibiotic resistance in pathogenic 
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